Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2023 | Jul. 31, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-34611 | |
Entity Registrant Name | CELSIUS HOLDINGS, INC. | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 20-2745790 | |
Entity Address, Address Line One | 2424 N Federal Highway | |
Entity Address, Address Line Two | Suite 208 | |
Entity Address, City or Town | Boca Raton | |
Entity Address, State or Province | FL | |
Entity Address, Postal Zip Code | 33431 | |
City Area Code | 561 | |
Local Phone Number | 276-2239 | |
Title of 12(b) Security | Common Stock, $0.001 par value | |
Trading Symbol | CELH | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 76,891,227 | |
Entity Central Index Key | 0001341766 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 681,054 | $ 614,159 |
Restricted cash | 0 | 38,768 |
Accounts receivable-net | 197,811 | 63,311 |
Note receivable-current | 3,323 | 2,979 |
Inventories-net | 152,545 | 173,289 |
Prepaid expenses and other current assets | 23,398 | 11,341 |
Deferred other costs-current | 14,124 | 14,124 |
Total current assets | 1,072,255 | 917,971 |
Note receivable-non-current | 0 | 3,574 |
Property and equipment-net | 15,892 | 10,185 |
Deferred tax asset | 28,373 | 501 |
Right of use assets-operating leases | 756 | 972 |
Right of use assets-finance leases | 171 | 208 |
Other long-term assets | 254 | 263 |
Deferred other costs-non-current | 255,400 | 262,462 |
Intangibles-net | 12,211 | 12,254 |
Goodwill | 13,937 | 13,679 |
Total Assets | 1,399,249 | 1,222,069 |
Current liabilities: | ||
Accounts payable and accrued expenses | 94,313 | 106,147 |
Income taxes payable | 58,798 | 1,193 |
Accrued distributor termination fees | 0 | 3,986 |
Accrued promotional allowance | 98,933 | 35,977 |
Lease liability obligation-operating leases | 505 | 661 |
Lease liability obligation-finance leases | 67 | 70 |
Deferred revenue-current | 9,500 | 9,675 |
Other current liabilities | 7,109 | 3,586 |
Total current liabilities | 269,225 | 161,295 |
Long-term liabilities: | ||
Lease liability obligation-operating leases | 249 | 326 |
Lease liability obligation-finance leases | 147 | 162 |
Deferred tax liability | 2,333 | 15,919 |
Deferred revenue-non-current | 171,745 | 179,788 |
Total Liabilities | 443,699 | 357,490 |
Commitments and contingencies (Note 19) | ||
Mezzanine Equity: | ||
Series A convertible preferred shares, $0.001 par value, 5% cumulative dividends; 1,467 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively, aggregate liquidation preference of $550,000 as of June 30, 2023 and December 31, 2022, respectively | 824,488 | 824,488 |
Stockholders’ Equity: | ||
Common stock, $0.001 par value; 100,000 shares authorized, 76,884 and 76,382 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 77 | 76 |
Additional paid-in capital | 278,980 | 280,668 |
Accumulated other comprehensive loss | (1,877) | (1,881) |
Accumulated deficit | (146,118) | (238,772) |
Total Stockholders’ Equity | 131,062 | 40,091 |
Total Liabilities, Mezzanine Equity and Stockholders’ Equity | $ 1,399,249 | $ 1,222,069 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Mezzanine equity, shares outatanding (in shares) | 1,467,000 | 1,467,000 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Common stock, shares issued (in shares) | 76,884,000 | 76,382,000 |
Common stock, shares outstanding (in shares) | 76,884,000 | 76,382,000 |
Series A Preferred Stock | ||
Mezzanine equity, par value (in USD per share) | $ 0.001 | $ 0.001 |
Mezzanine equity, cummulative dividend (percentage) | 5% | 5% |
Mezzanine equity, shares issued (in shares) | 1,467,000 | 1,467,000 |
Mezzanine equity, shares outatanding (in shares) | 1,467,000 | 1,467,000 |
Mezzanine equity, redemption amount | $ 550,000 | $ 550,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 325,883 | $ 154,020 | $ 585,822 | $ 287,408 |
Cost of revenue | 166,889 | 94,701 | 313,010 | 174,195 |
Gross profit | 158,994 | 59,319 | 272,812 | 113,213 |
Selling, general and administrative expenses | 94,181 | 46,889 | 163,086 | 90,667 |
Income from operations | 64,813 | 12,430 | 109,726 | 22,546 |
Other Income (Expense): | ||||
Interest income on note receivable | 28 | 55 | 73 | 133 |
Interest income (expense), net | 5,545 | (3) | 10,469 | (4) |
Foreign exchange loss | (931) | (514) | (1,049) | (676) |
Total other income (expense) | 4,642 | (462) | 9,493 | (547) |
Net income before income taxes | 69,455 | 11,968 | 119,219 | 21,999 |
Income tax expense | (17,946) | (2,810) | (26,483) | (6,161) |
Net income | 51,509 | 9,158 | 92,736 | 15,838 |
Dividends on Series A convertible preferred shares | (6,856) | 0 | (13,637) | 0 |
Income allocated to participating preferred shares | (3,796) | 0 | (6,727) | 0 |
Net income attributable to common stockholders | 40,857 | 9,158 | 72,372 | 15,838 |
Other comprehensive income: | ||||
Foreign currency translation (loss) gain, net of income tax | (590) | (2,296) | 4 | (2,787) |
Comprehensive income | $ 40,267 | $ 6,862 | $ 72,376 | $ 13,051 |
Earnings per share: | ||||
Basic (in USD per share) | $ 0.53 | $ 0.12 | $ 0.94 | $ 0.21 |
Dilutive (in USD per share) | $ 0.52 | $ 0.12 | $ 0.92 | $ 0.20 |
Weighted Average Number of Shares Outstanding, Diluted [Abstract] | ||||
Basic (in shares) | 76,845 | 75,451 | 76,759 | 75,472 |
Dilutive (in shaares) | 78,944 | 78,372 | 78,859 | 78,397 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Stockholders' Equity and Mezzanine Equity - USD ($) $ in Thousands | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment |
Beginning balance (in shares) at Dec. 31, 2021 | 74,909,000 | ||||||
Beginning balance at Dec. 31, 2021 | $ 217,046 | $ 75 | $ 267,847 | $ 614 | $ (51,490) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Stock-based compensation expense | 4,310 | 4,310 | |||||
Issuance of common stock pursuant to exercise of stock options and vested restricted stock units - cashless (in shares) | 248,000 | ||||||
Issuance of common stock pursuant to exercise of stock options - cash (in shares) | 194,000 | ||||||
Issuance of common stock pursuant to exercise of stock options - Cash | 810 | 810 | |||||
Foreign currency translation | (491) | (491) | |||||
Net income | 6,679 | 6,679 | |||||
Ending balance (in shares) at Mar. 31, 2022 | 75,351,000 | ||||||
Ending balance at Mar. 31, 2022 | 228,354 | $ 75 | 272,967 | 123 | (44,811) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Stock-based compensation expense | 4,207 | 4,207 | |||||
Issuance of common stock pursuant to exercise of stock options and vested restricted stock units - cashless (in shares) | 99,000 | ||||||
Issuance of common stock pursuant to exercise of stock options - cash (in shares) | 172,000 | ||||||
Issuance of common stock pursuant to exercise of stock options - Cash | 450 | $ 1 | 449 | ||||
Foreign currency translation | (2,296) | (2,296) | |||||
Net income | 9,158 | 9,158 | |||||
Ending balance (in shares) at Jun. 30, 2022 | 75,622,000 | ||||||
Ending balance at Jun. 30, 2022 | $ 239,873 | $ 76 | 277,623 | (2,173) | (35,653) | ||
Beginning balance (in shares) at Dec. 31, 2022 | 76,382,000 | 76,382,000 | |||||
Beginning balance at Dec. 31, 2022 | $ 40,091 | $ (82) | $ 76 | 280,668 | (1,881) | (238,772) | $ (82) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Stock-based compensation expense | 5,507 | 5,507 | |||||
Issuance of common stock pursuant to exercise of stock options and vested restricted stock units - cashless (in shares) | 251,000 | ||||||
Issuance of common stock pursuant to exercise of stock options and vested restricted stock units - Cashless | 1 | $ 1 | |||||
Issuance of common stock pursuant to exercise of stock options - cash (in shares) | 149,000 | ||||||
Issuance of common stock pursuant to exercise of stock options - Cash | 478 | 478 | |||||
Dividends paid to Series A convertible preferred shares | (6,781) | (6,781) | |||||
Foreign currency translation | 594 | 594 | |||||
Net income | 41,227 | 41,227 | |||||
Ending balance (in shares) at Mar. 31, 2023 | 76,782,000 | ||||||
Ending balance at Mar. 31, 2023 | $ 81,035 | $ 77 | 279,872 | (1,287) | (197,627) | ||
Beginning balance (in shares) at Dec. 31, 2022 | 1,467,000 | ||||||
Beginning balance at Dec. 31, 2022 | $ 824,488 | ||||||
Ending balance at Mar. 31, 2023 | $ 824,488 | ||||||
Ending balance (in shares) at Mar. 31, 2023 | 1,467,000 | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Stock-based compensation expense | $ 5,735 | 5,735 | |||||
Issuance of common stock pursuant to exercise of stock options and vested restricted stock units - cashless (in shares) | 63,000 | ||||||
Issuance of common stock pursuant to exercise of stock options and vested restricted stock units - Cashless | 0 | $ 0 | |||||
Issuance of common stock pursuant to exercise of stock options - cash (in shares) | 39,000 | ||||||
Issuance of common stock pursuant to exercise of stock options - Cash | 229 | 229 | |||||
Dividends paid to Series A convertible preferred shares | (6,856) | (6,856) | |||||
Foreign currency translation | (590) | (590) | |||||
Net income | $ 51,509 | 51,509 | |||||
Ending balance (in shares) at Jun. 30, 2023 | 76,884,000 | 76,884,000 | |||||
Ending balance at Jun. 30, 2023 | $ 131,062 | $ 77 | $ 278,980 | $ (1,877) | $ (146,118) | ||
Ending balance at Jun. 30, 2023 | $ 824,488 | ||||||
Ending balance (in shares) at Jun. 30, 2023 | 1,467,000 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Cash flows from operating activities: | |||||
Net income | $ 51,509 | $ 9,158 | $ 92,736 | $ 15,838 | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||||
Depreciation | 600 | 400 | 953 | 556 | |
Amortization | 294 | 275 | |||
Allowance for credit losses | 1,088 | 466 | |||
Amortization of deferred other costs | 7,062 | 0 | |||
Inventory excess and obsolescence | (3,888) | 331 | |||
Loss on disposal of property and equipment | 191 | 0 | |||
Stock-based compensation expense | 11,242 | 8,517 | |||
Deferred income taxes-net | (41,044) | 1,072 | |||
Foreign exchange loss | 206 | 602 | |||
Changes in operating assets and liabilities: | |||||
Accounts receivable-net | (135,600) | (27,920) | |||
Inventories-net | 24,632 | 28,753 | |||
Prepaid expenses and other current assets | (12,058) | 1,257 | |||
Accounts payable and accrued expenses | (12,491) | (7,176) | |||
Income taxes payable | 57,605 | 0 | |||
Accrued promotional allowance | 62,995 | 17,512 | |||
Accrued distributor termination fees | (3,986) | 0 | |||
Other current liabilities | 3,523 | 1,820 | |||
Change in right of use and lease obligation-net | (38) | (95) | |||
Deferred revenue | (8,219) | 0 | |||
Deferred revenue | 0 | 488 | |||
Other assets | 8 | 0 | |||
Net cash provided by operating activities | 45,211 | 42,296 | |||
Cash flows from investing activities: | |||||
Collections from note receivable | 3,233 | 2,592 | |||
Purchase of property and equipment | (6,810) | (2,456) | |||
Net cash (used in) provided by investing activities | (3,577) | 136 | |||
Cash flows from financing activities: | |||||
Principal payments on finance lease obligations | (22) | (37) | |||
Proceeds from exercise of stock options | 707 | 1,260 | |||
Dividends paid on preferred shares | (13,637) | 0 | |||
Net cash (used in) provided by financing activities | (12,952) | 1,223 | |||
Effect of exchange rate changes on cash and cash equivalents | (555) | 121 | |||
Net increase in cash and cash equivalents | 28,127 | 43,776 | |||
Cash and cash equivalents at beginning of the period | 652,927 | 16,255 | $ 16,255 | ||
Cash and cash equivalents at end of the period | $ 681,054 | $ 60,031 | 681,054 | 60,031 | $ 652,927 |
Cash paid for: | |||||
Taxes | $ 10,033 | $ 2,100 |
ORGANIZATION AND DESCRIPTION OF
ORGANIZATION AND DESCRIPTION OF BUSINESS | 6 Months Ended |
Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND DESCRIPTION OF BUSINESS | ORGANIZATION AND DESCRIPTION OF BUSINESS Business — Celsius Holdings, Inc. (the “Company” or “Celsius Holdings”) was incorporated under the laws of the State of Nevada on April 26, 2005. On January 24, 2007, the Company entered into a merger agreement and plan of reorganization with Elite FX, Inc., a Florida corporation. Under the terms of the Merger Agreement, Elite FX, Inc. was merged into the Company’s subsidiary, Celsius, Inc. and became a wholly-owned subsidiary of the Company on January 26, 2007. The Company is engaged in the development, marketing, sale and distribution of “functional” calorie-burning energy drinks and liquid supplements under the Celsius® brand name. On August 1, 2022, the Company and PepsiCo Inc. ("Pepsi"), entered into multiple agreements, including a Securities Purchase Agreement (“Purchase Agreement”), Lock-Up Agreements, Registration Rights Agreement, a distribution agreement (“Distribution Agreement”), and a Channel Transition Agreement ("Transition Agreement"). The Securities Purchase Agreement, Lock-Up Agreements and Registration Rights Agreement pertain to the Company’s issuance of approximately 1.5 million shares of Series A Convertible Preferred Stock (“Series A” or “Series A Preferred Stock”) in exchange for cash proceeds of $550 million, excluding transaction costs. The Transition Agreement specifies payments to be made by Pepsi to Celsius for transitioning certain existing distribution rights to Pepsi. The Distribution Agreement resulted in Pepsi becoming the Company’s primary distribution supplier for the Company's products in the United States. See Note 13. Related Party Transactions and Note 14. Mezzanine Equity for more information. In connection with the Distribution Agreement and Transition Agreement, the Company terminated agreements with existing suppliers to transition territory rights to Pepsi. These expenses were recognized by the Company upon delivery of termination notices to the other distributors, in accordance with ASC Topic 420 Exit or Disposal Cost Obligations . As of the six months ended June 30, 2023, projected payments less the payments received were refunded. See Note 13 . Related Party Transactions for more information. |
BASIS OF PRESENTATION AND SUMMA
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation — The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and notes required by US GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. The results for the three and six months ended June 30, 2023 are not necessarily indicative of the results expected for any future period or the full year. These unaudited consolidated financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and the Amendment No. 1 to the Annual Report on Form 10-K/A (collectively the "2022 Annual Report"). These unaudited consolidated financial statements and the accompanying notes should be read in conjunction with the 2022 Annual Report. The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform with current period presentation in the consolidated financial statements and notes thereto. Accrued promotional allowance and income tax payable were reallocated from within Accounts payable and accrued expenses and are now reflected as standalone line items in the consolidated balance sheets and consolidated statements of cash flows, respectively. Significant Estimates — The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for current expected credit losses, allowance for inventory obsolescence and sales returns, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred taxes and related valuation allowance, promotional allowance, and valuation of stock-based compensation. Segment Reporting — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker ("CODM") to make decisions about allocating resources and to assess performance. Even though the Company has operations in several geographies, it operates as a single enterprise. The Company's operations and strategies are centrally designed and executed given that the geographical components are very similar. The CODM (the Chief Executive Officer) reviews operating results primarily from a consolidated perspective, and makes decisions and allocates resources based on that review. The reason the Company's CODM focuses on consolidated results in making decisions and allocating resources is because of the significant economic interdependencies between the Company's geographical operations and the Company’s U.S. entity. Concentrations of Risk — Substantially all of the Company’s revenue is derived from the sale of Celsius® functional energy drinks and liquid supplements. Revenue from customers accounting for more than 10% of total revenue for the three and six months ended June 30, 2023 and 2022 are as follows: For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 Pepsi 56.7 % — % 58.3 % — % Costco 13.0 % 15.9 % 12.9 % 16.6 % All others 30.3 % 84.1 % 28.8 % 83.4 % Total 100.0 % 100.0 % 100.0 % 100.0 % Accounts receivable from customers accounting for more than 10% of total accounts receivable for the six months ended June 30, 2023 and the year ended December 31, 2022 are as follows: 2023 2022 Pepsi 68.4 % 47.6 % Amazon 10.7 % 11.8 % All others 20.9 % 40.6 % Total 100.0 % 100.0 % Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and note receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At June 30, 2023 and December 31, 2022, the Company had approximately $680.6 million and $652.4 million in excess of the Federal Deposit Insurance Corporation limit. Cash Equivalents — The Company considers all highly liquid instruments with original maturities of three months or less when purchased to be cash equivalents. At June 30, 2023 and December 31, 2022, the Company did not have any investments with original maturities of three months or less. Restricted Cash — The Company received upfront payments from Pepsi during 2022, which were contractually restricted and could only be used to satisfy termination payments due to former distributors or must be repaid to Pepsi. These upfront payments received from Pepsi could not be used for general operating activities of the Company and were classified as restricted cash based on the terms of the Transition Agreement. See Note 4. Revenue for more information. At June 30, 2023, the Company did not have restricted cash. At December 31, 2022, the Company had $38.8 million of restricted cash. Accounts Receivable and Current Expected Credit Losses — The Company is exposed to potential credit risks associated with its product sales and related accounts receivable, as it generally does not require collateral. The Company’s expected loss allowance methodology for accounts receivable is developed using historical collection experience, current and future economic and market conditions, a review of the current status of customers’ trade accounts receivables, and where available, a review of the financial strength and credit ratings of larger customers. Customers are pooled based on sharing specific risk factors and the Company reassesses these customer pools on a periodic basis. The receivables allowance is based on aging of the accounts receivable balances and forward-looking information. The Company uses the probability of default and forward-looking information to assess credit risk and estimate expected credit losses for its note receivable related to Qifeng Food Technology (Beijing) Co. Ltd ("Qifeng"). See Note 7. Note Receivable for more information on Qifeng and the note receivable. The Company determines expected credit losses using information such as its customers' credit history, financial condition, industry, credit reports, and current and future economic and market conditions. Allowances can be affected by changes in the industry, customer credit issues or customer bankruptcies when such events are reasonable and supportable. Historical information is used in addition to reasonable and supportable forecast periods. Allowance for Expected Credit Losses Balance as of December 31, 2022 $ 2,147 Current period change for expected credit losses (118) Balance as of June 30, 2023 $ 2,029 Inventories — Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. At June 30, 2023 and December 31, 2022, there was an inventory allowance for excess and obsolete products of approximately $4.5 million and $8.4 million, respectively. The changes in the allowance are included in cost of revenue. Property and Equipment — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset, generally ranging from three Impairment of Long-Lived Assets — In accordance with ASC Topic 360, Property, Plant, and Equipment the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset, if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairment charges during the six months ended June 30, 2023 and 2022. Long-Lived Asset Geographic Data — The following table sets forth long-lived asset information, which includes property and equipment-net, right-of-use assets, and definite-lived intangibles and excludes goodwill and indefinite-lived intangibles, where individual countries represent a significant portion of the total: June 30, December 31, United States $ 15,042 $ 9,750 Finland 12,165 12,171 Sweden 1,338 1,251 Other 29 1 Long-lived assets related to foreign operations 13,532 13,423 Total long-lived assets-net $ 28,574 $ 23,173 Goodwill — The Company records goodwill when the consideration paid for an acquisition exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1st, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. At June 30, 2023 and December 31, 2022, there were no indicators of impairment. Intangible Assets — Intangible assets are comprised of customer relationships and brands acquired in a business combination. In accordance with ASC Topic 350, Intangibles - Goodwill, and Other, the Company amortizes intangible assets with a definitive life over their respective useful lives. The Company tests intangible long-lived assets for impairment when events suggest that the carrying amount may not be recoverable. The test involves comparing the asset's carrying amount to its estimated undiscounted future cash flows. If the carrying amount exceeds these cash flows, an impairment loss, equal to the difference between the carrying amount and the fair value, is recognized. Assets with indefinite lives are tested for impairment on an annual basis as of October 1st or more frequently if the Company believes impairment exists. At June 30, 2023, there were no indicators of impairment. Revenue Recognition — The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers ("ASC 606"). Revenue is recognized when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred based on the commercial terms of the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. See Note 4. Revenue for more information. Deferred Revenue — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. As of June 30, 2023, the Company had approximately $181.2 million in deferred revenue, of which $171.7 million is classified as deferred revenue-non-current and $9.5 million is classified as deferred revenue-current in the consolidated balance sheets and are contract liabilities related to Pepsi which are recognized ratably over the twenty Related Party Transactions for more information. Accrued Distributor Termination Fees — Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company did not have any accrued distributor termination fees as of June 30, 2023. Refer to Note 13. Related Party Transactions for more information. Customer Advances — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within deferred revenue. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. The Company had no customer advances as of June 30, 2023 or December 31, 2022, respectively. Advertising Costs — Advertising costs are expensed as incurred and charged to selling, general and administrative expenses. The Company mainly uses radio, local sampling events, sponsorships, endorsements, and digital advertising. The Company incurred marketing and advertising expenses of approximately $36.5 million and $14.8 million, respectively, during the three months ended June 30, 2023 and 2022. During the six months ended June 30, 2023 and 2022, the Company incurred marketing and advertising expenses of approximately $67.5 million and $29.3 million, respectively. Research and Development — Research and development costs are charged to selling, general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. The Company incurred expenses of approximately $0.2 million and $0.1 million, respectively, during the three months ended June 30, 2023 and 2022. During the six months ended June 30, 2023 and 2022, the Company incurred research and development expenses of approximately $0.5 million and $0.2 million, respectively. Foreign Currency Gain/Loss — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments related to fluctuations in foreign exchange rates versus the U.S. dollar are included in the Statements of Operations as foreign exchange gains or losses. For the three months ended June 30, 2023 exchange loss was approximately $0.9 million versus foreign exchange loss of approximately $0.5 million during the three months ended June 30, 2022. For the six months ended June 30, 2023, the foreign exchange loss was approximately $1.0 million versus approximately $0.7 million during the six months ended June 30, 2022. Translation gains and losses that arise from the translation of net assets from functional currency to the reporting currency, as well as exchange gains and losses on intercompany balances of long-term investment nature, are included in Other Comprehensive Income, net of tax. The Company incurred a foreign currency translation net loss during the three months ended June 30, 2023 of approximately $0.6 million and a net loss of approximately $2.3 million during the three months ended June 30, 2022. The Company incurred foreign currency translation net gains of less than $0.1 million during the six months ended June 30, 2023 and a net loss of approximately $2.8 million during the six months ended June 30, 2022. The Company's primary operations in different countries required that it transacts in the following currencies: Chinese-Yuan Hong Kong-Hong Kong Dollar Norwegian-Krone Swedish-Krona Finland-Euro United Kingdom-Pound Sterling Fair Value of Financial Instruments — The carrying value of cash and cash equivalents, accounts receivable, accounts payable, other current liabilities, note receivable and accrued expenses approximate fair value due to their relative short-term maturity and market interest rates. Income Taxes — The Company accounts for income taxes pursuant to the provisions of ASC Topic 740-10, Accounting for Income Taxes ("ASC 740-10"), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more-likely-than-not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more-likely-than-not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company affirms a tax position as effectively settled upon the completion of an examination by a taxing authority, irrespective of whether the position has been legally extinguished, as per ASC 740-10-25 Definition of Settlement . By doing so, the Company ensures the recognition of previously unrecognized tax benefits. This policy allows the Company to record the full amount of tax benefit related to each tax position, even in cases where, based solely on its technical merits, the tax position is not seen as more-likely-than-not to be sustained and the statute of limitations remains open. The Company’s tax returns for tax years in 2020 through 2022 remain subject to potential examination by the taxing authorities. Earnings per Share — The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share ("EPS") for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating preferred stockholders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings. See Note 3. Earnings per Share for more information. Stock-Based Compensation — The Company follows the provisions of ASC Topic 718 Compensation — Stock Compensation and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the stock-based compensation. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the "2015 Plan"). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other stock-based awards for up to 5 million shares. In addition, there is a provision for an annual increase of 15% to the shares included under the plan, with the shares to be added on the first day of each calendar year, beginning on January 1, 2016. See Note 18. Stock-Based Compensation for more information. Cost of Revenue — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacturing of products, co-packing fees, repacking fees, in-bound & out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacturing of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of revenue. Raw materials include cans, bottles, other containers, flavors, ingredients, and packaging materials. Operating Expenses — Operating expenses include selling expenses such as warehousing expenses after manufacturing, as well as expenses for advertising, samplings and in-store demonstrations, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also includes costs such as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs. These expenses are included in selling, general and administrative expenses in the consolidated statements of operations and comprehensive income. Shipping and Handling Costs — Shipping and handling costs for freight expense on goods shipped are included in cost of revenue. Freight expense on goods shipped for the three months ended June 30, 2023 and 2022 was approximately $14.9 million and $8.5 million, respectively. Freight expense on goods shipped for the six months ended June 30, 2023 and 2022 was approximately $29.1 million and $11.4 million, respectively. These expenses are included in selling, general and administrative expenses in the consolidated statements of operations and comprehensive income. Recent Accounting Pronouncements The Company adopts all applicable, new accounting pronouncements as of the specified effective dates. Effective January 1, 2023, the Company adopted ASU 2016-13 Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("CECL") , |
EARNINGS PER SHARE
EARNINGS PER SHARE | 6 Months Ended |
Jun. 30, 2023 | |
Earnings Per Share [Abstract] | |
EARNINGS PER SHARE | EARNINGS PER SHARE Basic earnings per common share is computed by dividing income or loss attributable to common stockholders by the weighted average number of shares of basic common stock outstanding. The Company’s Series A Convertible Preferred Stock is classified as a participating security in accordance with ASC 260. Net income allocated to the holders of Series A Convertible Preferred Stock was calculated based on the stockholders’ proportionate share of weighted average shares of common stock outstanding on an if-converted basis. For purposes of determining diluted earnings per common share, basic earnings per common share was further adjusted to include the effect of potential dilutive common shares outstanding, including unvested restricted stock and performance-based stock units, using the more dilutive of either the two-class method or the treasury stock method, and Series A Convertible Preferred Stock using the if-converted method. Stock options and warrants that were out-of-the-money were not included in the denominator for the calculation of diluted EPS. Under the two-class method of calculating diluted earnings per share, net income is reallocated to common stock, the Series A Convertible Preferred Stock, and all dilutive securities based on the contractual participating rights of the security to share in the current earnings as if all of the earnings for the period had been distributed. For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 Numerator: Net income $ 51,509 $ 9,158 $ 92,736 $ 15,838 Less: dividends paid to Series A convertible preferred stockholders (6,856) — (13,637) — Undistributed income 44,653 9,158 79,099 15,838 Income allocated to participating preferred shares (3,796) — (6,727) — Net income attributable to common stockholders $ 40,857 $ 9,158 $ 72,372 $ 15,838 Denominator: Weighted average basic common shares outstanding 76,845 75,451 76,759 75,472 Dilutive effect of common shares 2,099 2,921 2,100 2,925 Weighted average diluted shares outstanding 78,944 78,372 78,859 78,397 Earnings per share: Basic $ 0.53 $ 0.12 $ 0.94 $ 0.21 Dilutive $ 0.52 $ 0.12 $ 0.92 $ 0.20 For the three and six months ended June 30, 2023, 7.3 million of potentially dilutive securities were excluded from the computation of diluted net income per share related to common stockholders as their effect was antidilutive. |
REVENUE
REVENUE | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Revenue [Abstract] | |
REVENUE | REVENUE The Company recognizes revenue in accordance with ASC 606. Revenue is recognized when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred based on the commercial terms. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. Product sales are recorded net of variable consideration, such as provisions for returns, discounts and promotional allowances. Such provisions are calculated using historical averages and adjusted for any expected changes due to current business conditions. Consideration given to customers for cooperative advertising is recognized as a reduction of revenue except to the extent that there is a distinct good or service, in which case the expense is classified as selling or marketing expense. The amount of consideration the Company receives and revenue the Company recognizes varies with changes in customer incentives that the Company offers to its customers and their customers. Additionally, for any agreements which are one year or less, the practical expedient under ASC 340-40-25-4 is applied to expense contract acquisition costs when incurred if the amortization period of the contract asset would have otherwise been recognized in one year or less. Promotional (Billback) Allowance The Company’s billback allowance programs with its distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described below and are of varying durations, typically ranging from one week to one year. The Company’s billbacks are calculated based on various programs with distributors and retail customers, and accruals are established for the Company’s anticipated liabilities. These accruals are based on agreed upon terms as well as the Company’s historical experience with similar programs and require management’s judgment with respect to estimating consumer participation and/or distributor and retail customer performance levels. Differences between such estimated expenses and actual expenses for promotional and other allowance costs have historically been insignificant and are recognized in earnings in the period such differences are determined. Billbacks (variable consideration) recorded as a reduction to net sales primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: • discounts granted off list prices to support price promotions to end-consumers by retailers; • reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; • the Company’s agreed share of fees given to distributors and/or directly to retailers for advertising, in-store marketing and promotional activities; • the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers, club stores and/or wholesalers; • incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined volume goals; • discounted products; • contractual fees given to the Company’s distributors related to sales made directly by the Company to certain customers that fall within the distributors’ sales territories; and • contractual fees given to distributors for items sold below defined pricing targets. For the three months ended June 30, 2023 and 2022, promotional allowance included as a reduction of revenue were $86.4 million and $37.9 million, respectively. For the six months ended June 30, 2023 and 2022, promotional allowance included as a reduction of revenue were $151.9 million and $73.2 million, respectively. Accrued promotional allowances were $98.9 million and $36.0 million as of June 30, 2023 and December 31, 2022, respectively. Information about the Company’s net sales by geographical location for the three and six months ended June 30, 2023 and 2022 is as follows: For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 North America $ 310,815 $ 145,409 $ 559,367 $ 268,882 Europe 11,909 7,280 20,561 15,775 Asia-Pacific 1,606 883 2,864 1,849 Other 1,553 448 3,030 902 Net sales $ 325,883 $ 154,020 $ 585,822 $ 287,408 All of the Company’s North America revenue is derived from the United States, which is the Company’s country of domicile. Sweden represented the largest foreign portion of total consolidated revenue of approximately $7.9 million and $5.1 million for the three months ended June 30, 2023 and 2022, respectively. Sweden represented the largest foreign portion of total consolidated revenue of approximately $13.4 million and $10.8 million for the six months ended June 30, 2023 and 2022, respectively. Agreements with Pepsi The Company executed multiple agreements with Pepsi on August 1, 2022, including a Distribution Agreement relating to the sale and distribution of certain of the Company’s beverage products in existing channels and distribution methods in the United States, excluding certain existing customer accounts, sales channels, Puerto Rico and the US Virgin Islands (the “Territory”). Under the Distribution Agreement, the Company has granted Pepsi the right to sell and distribute its existing beverage products in existing channels and distribution methods and future beverage products that are added from time to time as licensed products under the Distribution Agreement in defined territories. The Distribution Agreement represents a master service agreement and can be cancelled by either party without cause in the nineteen The Company agreed to provide Pepsi a right of first offer in the event the Company intends to (i) manufacture, distribute or sell products in certain additional countries as specified in the Distribution Agreement or (ii) distribute or sell products in any future channels and distribution methods during the term of the Agreement. Additionally, pursuant to the Distribution Agreement, the Company and Pepsi agreed to use commercially reasonable efforts to negotiate and execute with Pepsi a distribution agreement reasonably consistent with the Distribution Agreement for the sale and distribution of the Products in Canada, and Pepsi agreed to meet and confer in good faith with the Company regarding the terms and conditions upon which Pepsi may be willing to sell or distribute the Products, either directly or through local sub-distributors in certain other additional countries. The Distribution Agreement includes other customary provisions, including non-competition covenants in favor of the Company, representations and warranties, indemnification provisions, insurance provisions and confidentiality provisions. The Company and Pepsi also executed the Transition Agreement, providing for the Company’s transition of certain existing distribution rights in the Territory to Pepsi. Under the terms of the Transition Agreement, Pepsi would pay the Company up to $250 million in multiple tranches to facilitate the Company’s transition of certain distribution rights to Pepsi. Amounts received from Pepsi were contractually restricted to only be used to pay termination fees due to other distributors; any excess cash received over amounts due to other distributors is to be refunded back to Pepsi. Accounting for the agreements executed with Pepsi. The Company evaluated the Securities Purchase Agreement, Transition Agreement, Distribution Agreement, and other agreements executed with Pepsi on August 1, 2022, as one combined contract since the agreements were executed on the same day, with the same counterparty, in contemplation of one another and contractual terms are defined and referenced across the agreements. These agreements will be referred to as the “Pepsi Arrangement” herein. Management concluded the Pepsi Arrangement was partially in the scope of ASC 606 and partially in the scope of ASC 505, Equity (“ASC 505") and ASC 480, Distinguishing liabilities from equity ("ASC 480"). The Company first applied the measurement and classification criteria in ASC 505 and ASC 480 with respect to the Company’s issuance of approximately 1.5 million shares of Series A Convertible Preferred Stock, as the substance of the issuance of the Series A Convertible Preferred Stock was determined to be a financing transaction. See Note 14. Mezzanine Equity for more information. After application of the measurement and classification principles in ASC 505, and ASC 480, the Company accounted for the residual revenue elements of the Pepsi Arrangement under ASC 606. The revenue elements of the Pepsi Arrangement consisted of (i) a $227.8 million upfront payment under the Transition agreement and (ii) a $282.5 million implicit payment made to Pepsi by Celsius, representing the excess fair value over issuance proceeds received for the Series A Convertible Preferred Stock. See Note 13 . Related Party Transactions for more information on the upfront payment and implicit payment related to the excess in fair value over issuance proceeds. The $282.5 million excess fair value over issuance proceeds of the Series A Convertible Preferred Stock represents an implicit payment made to a customer. The Company concluded that this implicit payment meets the definition of an asset and has been recorded as a deferred other cost in the consolidated balance sheets, with a portion included as current representing current year amortization in the Company's consolidated balance sheets. The Company will amortize the asset balance as contra-revenues ratably over a twenty For product sales under the Distribution Agreement, the Company will recognize revenues when control of the underlying goods are transferred to Pepsi based on the contractual terms of noncancellable purchase orders issued by Pepsi. The Company’s customary revenue recognition policy as explained above is applied with respect to rebates. License Agreement In January 2019, the Company entered into a license and repayment of investment agreement with Qifeng. Under the agreement, Qifeng was granted the exclusive license rights to manufacture, market and commercialize Celsius branded products in China. The term of the agreement is 50 years, with annual royalty fees due from Qifeng after the end of each calendar year. The royalty fees are based on a percentage of Qifeng’s sales of Celsius branded products; however, the fees are fixed for the first five years of the agreement, totaling approximately $6.9 million, and then are subject to annual guaranteed minimums over the remaining term of the agreement. Under the agreement, the Company grants Qifeng exclusive license rights and provides ongoing support in product development, brand promotion and technical expertise. The ongoing support is integral to the exclusive license rights and, as such, both of these represent a combined, single performance obligation. The transaction price consists of the guaranteed minimums and the variable royalty fees, all of which are allocated to the single performance obligation. The Company recognizes revenue from the agreement over time because Qifeng simultaneously receives and consumes the benefits from the services. The Company uses the passage of time to measure progress towards satisfying its performance obligation because of its ongoing efforts in providing the exclusive license rights including providing continuous access, updates and support. Total revenue recognized under the agreement was approximately $0.5 million and $0.5 million, respectively, for the three months ended June 30, 2023 and 2022, and approximately $1.1 million and $1.0 million, respectively, for the six months ended June 30, 2023 and 2022, which is reflected in revenues from Asia-Pacific. |
INVENTORIES
INVENTORIES | 6 Months Ended |
Jun. 30, 2023 | |
Inventory Disclosure [Abstract] | |
INVENTORIES | INVENTORIES Inventories, net consist of the following: June 30, December 31, Finished goods $ 95,766 $ 119,229 Raw materials 61,322 62,491 Less: Inventory reserve (4,543) (8,431) Inventories-net $ 152,545 $ 173,289 |
PREPAID EXPENSES AND OTHER CURR
PREPAID EXPENSES AND OTHER CURRENT ASSETS | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Prepaid Expenses And Other Current Assets [Abstract] | |
PREPAID EXPENSES AND OTHER CURRENT ASSETS | PREPAID EXPENSES AND OTHER CURRENT ASSETSPrepaid expenses and other current assets total approximately $23.4 million and $11.3 million at June 30, 2023 and December 31, 2022, respectively, consisting mainly of prepaid advances to co-packers related to inventory production, advertising, prepaid insurance, prepaid slotting fees, value added tax payments and deposits on purchases. |
NOTE RECEIVABLE
NOTE RECEIVABLE | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Note Receivable [Abstract] | |
NOTE RECEIVABLE | NOTE RECEIVABLE Note receivable consists of the following: June 30, December 31, Note receivable-current $ 3,392 $ 2,979 Current period change for expected credit losses (1) (69) — Note receivable-non-current — 3,574 Total $ 3,323 $ 6,553 (1) Upon adoption of CECL in Q1 2023, the Company recorded a reserve for estimated expected credit losses associated with the note receivable. Effective January 1, 2019, the Company restructured its China distribution efforts by entering into two separate economic agreements as it relates to the commercialization of its Celsius products (i.e., the license and repayment of investment agreement with Qifeng). See Note 4. Revenue for information regarding the license agreement with Qifeng. Under a separate economic agreement, Qifeng will repay the marketing investments made by Celsius into the China market through 2018, over a five-year period. The repayment, which was formalized via a note receivable from Qifeng (the "Note"), will need to be serviced even if the licensing agreement is cancelled or terminated. The Note is denominated in Chinese-Yuan. Scheduled principal payments plus accrued interest for the Note are due annually on March 31 of each year starting in 2020. The note receivable is recorded at amortized cost and accrues interest at a rate per annum initially equal to the weighted average of 5% of the outstanding principal up to $5 million and 2% of the outstanding principal above $5 million. On June 12, 2020, it was agreed to fix the interest rate at 3.21% which reflected the weighted average interest rate for the 5-year period of the Note. For the three months ended June 30, 2023 and 2022, interest income was immaterial and $0.1 million, respectively. For the six months ended June 30, 2023 and 2022, interest income was approximately $0.1 million and $0.1 million, respectively. The Company assesses the note receivable for impairment at each reporting period, by evaluating whether it is probable that the Company will be unable to collect all the contractual principal and interest payments as scheduled in the Note, based on historical experience of Qifeng’s ability to pay, the current economic environment, forward-looking information and other factors. If the Note is determined to be impaired, the impairment is measured based on the present value of the expected future cash flows under the Note, discounted at the Note’s effective interest rate. At June 30, 2023 and December 31, 2022, the Note was not deemed to be impaired. Payment in-full was received pertaining to the amounts due on March 31, 2023. |
LEASES
LEASES | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Leases [Abstract] | |
LEASES | LEASES The Company’s leasing activities include operating leases for its corporate office space from a related party (see Note 13. Related Party Transactions ) and other operating and finance leases of vehicles and office space for the Company’s European operations. The future annual minimum lease payments required under the Company’s operating and finance lease liabilities as of June 30, 2023 are as follows: Future minimum lease payments Operating Finance Total 2023 $ 334 $ 52 $ 386 2024 369 40 409 2025 54 68 122 2026 31 65 96 2027 — — — Total future minimum lease payments 788 225 1,013 Less: Amount representing interest (34) (11) (60) Present value of lease liabilities 754 214 953 Less: current portion (505) (67) (674) Long-term portion $ 249 $ 147 $ 279 |
LEASES | LEASES The Company’s leasing activities include operating leases for its corporate office space from a related party (see Note 13. Related Party Transactions ) and other operating and finance leases of vehicles and office space for the Company’s European operations. The future annual minimum lease payments required under the Company’s operating and finance lease liabilities as of June 30, 2023 are as follows: Future minimum lease payments Operating Finance Total 2023 $ 334 $ 52 $ 386 2024 369 40 409 2025 54 68 122 2026 31 65 96 2027 — — — Total future minimum lease payments 788 225 1,013 Less: Amount representing interest (34) (11) (60) Present value of lease liabilities 754 214 953 Less: current portion (505) (67) (674) Long-term portion $ 249 $ 147 $ 279 |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 6 Months Ended |
Jun. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT | PROPERTY AND EQUIPMENT Property and equipment-net consists of the following: Estimated Useful Life in Years June 30, December 31, Merchandising equipment - coolers 3-7 $ 14,962 $ 9,885 Office equipment 3-7 1,286 1,124 Vehicles 5 2,596 1,257 Less: accumulated depreciation (2,952) (2,081) Total $ 15,892 $ 10,185 Depreciation expense amounted to approximately $0.6 million and $0.4 million for the three months ended June 30, 2023 and 2022, respectively. Depreciation expense amounted to approximately $1.0 million and $0.6 million for the six months ended June 30, 2023 and 2022, respectively. |
GOODWILL AND INTANGIBLES
GOODWILL AND INTANGIBLES | 6 Months Ended |
Jun. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
GOODWILL AND INTANGIBLES | GOODWILL AND INTANGIBLES At June 30, 2023 and December 31, 2022, goodwill consists of approximately $13.9 million and $13.7 million, respectively, resulting from the excess of the consideration paid over the fair value of net tangible and intangible assets acquired from the Func Food acquisition. Intangible assets consist of acquired customer relationships and brands from the Func Food acquisition. The carrying amount and accumulated amortization of intangible assets as of June 30, 2023 and December 31, 2022, respectively, were as follows: June 30, December 31, Definite-lived intangible assets Customer relationships $ 13,670 $ 13,418 Less: accumulated amortization (1,914) (1,610) Definite-lived intangible assets, net $ 11,756 $ 11,808 Indefinite-lived intangible assets Brands $ 446 $ 2,984 Less: impairment — (2,576) Effect of exchange rate changes 9 38 Indefinite-lived intangible assets, net $ 455 $ 446 Intangibles-net $ 12,211 $ 12,254 Customer relationships are amortized over an estimated useful life of 25 years and brands have an indefinite life. Amortization expense for the three months ended June 30, 2023 and 2022 was approximately $0.1 million, and $0.1 million, respectively. Amortization expense for the six months ended June 30, 2023 and 2022 was approximately $0.3 million, and $0.3 million, respectively. Amortization expense is reflected in selling, general and administrative expenses. See Note 2. Basis of Presentation and Summary of Significant Accounting Policies , for more information regarding the indefinite-lived intangible asset, Brands. Other fluctuations in the amounts of goodwill and intangible assets are due to currency translation adjustments. The following is the future estimated annualized amortization expense related to customer relationships: 2023 $ 273 2024 547 2025 547 2026 547 2027 547 Thereafter 9,295 Total $ 11,756 |
ACCOUNTS PAYABLE AND ACCRUED EX
ACCOUNTS PAYABLE AND ACCRUED EXPENSES | 6 Months Ended |
Jun. 30, 2023 | |
Payables and Accruals [Abstract] | |
ACCOUNTS PAYABLE AND ACCRUED EXPENSES | ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: June 30, December 31, Accounts payable $ 26,039 $ 36,248 Due to Pepsi (1) — 34,807 Accrued freight 4,472 8,532 Accrued expenses 31,514 7,425 Accrued legal 12,403 10,463 Unbilled purchases 19,885 8,672 Total $ 94,313 $ 106,147 (1) See Note 13. Related Party Transactions for more information related to Pepsi. |
OTHER CURRENT LIABILITIES
OTHER CURRENT LIABILITIES | 6 Months Ended |
Jun. 30, 2023 | |
Payables and Accruals [Abstract] | |
OTHER CURRENT LIABILITIES | OTHER CURRENT LIABILITIES Other current liabilities consist of the following: June 30, December 31, VAT payable $ 591 $ 198 State Beverage Container Deposit 6,518 3,388 Total $ 7,109 $ 3,586 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 6 Months Ended |
Jun. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS Transactions with Pepsi As further described in Note 14. Mezzanine Equity , on August 1, 2022, the Company issued approximately 1.5 million shares of non-voting Series A to Pepsi. On an as-converted basis, the Series A held by Pepsi accounted for approximately 8.5% of the Company’s outstanding common stock on the date of issuance. Also, as discussed in Note 14, the Purchase Agreement entered into on August 1, 2022 granted Pepsi the right to designate a nominee for election to the Company’s nine-member board of directors, so long as Pepsi meets certain ownership requirements with respect to the Company’s stock. During the year ended 2022, a Pepsi executive was nominated by Pepsi and elected to the Company’s board of directors. Based on Pepsi’s contractual representation rights for a seat on the Company’s Board of Directors, the Company concluded that Pepsi represents a related party to the Company. The following transactions were recognized in the Company’s financial statements: • Net sales to Pepsi amounted to $184.9 million and $341.4 million, respectively, for the three and six months ended June 30, 2023 and are included in revenue on the accompanying consolidated statements of operations and comprehensive income. • Estimated promotional allowance related to Pepsi was $49.5 million at June 30, 2023 and is included in accrued promotional allowance in the Company's consolidated balance sheets. • Accounts receivable due from Pepsi on June 30, 2023 and December 31, 2022, were $138.0 million and $31.6 million, respectively, and are included in accounts receivable, net on the Company’s consolidated balance sheets. • Pepsi paid the Company $227.8 million in cash under the Transition Agreement during the year ended 2022. This amount was used to pay termination fees owed by the Company to terminated distributors; any excess cash received from Pepsi was contractually restricted and due back to Pepsi. The Company recorded deferred revenues (a contract liability) of $181.2 million, which is presented net of $2.3 million and $4.7 million, respectively, of revenue recognized in the consolidated statements of operations for the three and six months ended June 30, 2023. The Company recorded deferred revenues of $189.5 million, net of $4.2 million of revenue recognized as of December 31, 2022. The deferred revenues will be recognized by Celsius ratably over the twenty-year agreement term. • Amounts due to Pepsi of $34.8 million as of December 31, 2022, representing refund liabilities owed to Pepsi under the Transition Agreement, were recorded to accounts payable and accrued expenses on the accompanying consolidated balance sheets. As of June 30, 2023, payments due to Pepsi were fully refunded, and the Company did not have a refund liability. • The issuance of Series A to Pepsi was recorded at fair value, determined to be $832.5 million, on August 1, 2022. Cash proceeds from the issuance of Series A received from Pepsi were $550 million. See Note 14. Mezzanine Equity for more information. • The Company recorded a $282.5 million asset as deferred other costs in the consolidated balance sheets, representing the excess of the $832.5 million fair value of the Series A Preferred Stock over the issuance proceeds of $550 million. As of June 30, 2023 amounts representing the unamortized deferred other costs of $14.1 million and $255.4 million, respectively, are presented in deferred other costs-current and deferred other costs-non-current in the consolidated balance sheets. As of December 31, 2022 amounts representing the unamortized deferred other costs of $14.1 million and $262.5 million, respectively, are presented in deferred other costs-current and deferred other costs-non-current in the consolidated balance sheets. Amortization for the three and six months ended June 30, 2023, was $3.6 million and $7.1 million, respectively. This was recorded as an offset of revenue in the consolidated statements of operations and comprehensive income. See Notes 1. Organization and Description of Business, 2. Basis of Presentation and Summary of Significant Accounting Policies, 4. Revenue, 11. Accounts Payable and Accrued Expenses, and 14. Mezzanine Equity for more information. Related Party Lease The Company’s office is leased from a company affiliated with CD Financial, LLC which is controlled by a major stockholder. The lease extends until December 2024 with a monthly rent of $35 thousand. Additionally, on May 17, 2023, the Company and CD Financial, LLC entered into an amendment to the lease that expands the leased space, commencing July 1, 2023. The expansion space extends until December 2024 with a monthly rent of $8 thousand. |
MEZZANINE EQUITY
MEZZANINE EQUITY | 6 Months Ended |
Jun. 30, 2023 | |
Mezzanine Equity [Abstract] | |
MEZZANINE EQUITY | MEZZANINE EQUITY Series A Convertible Preferred Stock As of June 30, 2023 and December 31, 2022, the Company designated and authorized approximately 1.5 million shares of Series A Convertible Preferred Stock with a par value of $0.001 per share and a stated value of $375 per share. The stated value per share may be increased from time to time in the event dividends on the Series A are paid-in-kind (“PIK Dividends”) pursuant to the Series A Certification of Designation (the “Series A Certificate”). On August 1, 2022, pursuant to the Purchase Agreement, the Company issued approximately 1.5 million shares of Series A, representing 100% of the authorized Series A shares, to Pepsi for stated cash consideration aggregating $550 million, excluding issuance costs. The Series A was issued concurrently with the execution of the Distribution Agreement and the Transition Agreement. The Company determined that the aggregate fair value of the Series A on the issuance date was $832.5 million, or approximately $568 per share. Accordingly, the Series A Convertible Preferred Stock was recorded at that amount, net of issuance costs of $8.0 million, in the Company’s consolidated balance sheets. Mezzanine Classification The Series A Convertible Preferred Stock is redeemable in the event of a change in control as defined in the Series A Certificate. S99-3A(2) of the SEC's Accounting Series Release No. 268 ("ASR 268") requires preferred securities that are redeemable for cash or other assets to be classified outside of permanent equity if they are redeemable (i) at a fixed or determinable price on a fixed or determinable date, (ii) at the option of the holder, or (iii) upon the occurrence of an event that is not solely within the control of the issuer. Preferred securities that are mandatorily redeemable are required to be classified by the issuer as liabilities whereas under ASR 268, an issuer should classify a preferred security whose redemption is contingent on an event not entirely in control of the issuer as mezzanine equity. The Series A is not mandatorily redeemable, however, a change in control is not solely in control of the Company, and accordingly, the Company determined that mezzanine treatment is appropriate for the Series A and has presented it as such in the consolidated balance sheets and consolidated statements of changes in stockholders' equity and mezzanine equity as of and for the periods ending June 30, 2023 and December 31, 2022, respectively. The Series A is not considered mandatorily redeemable. Pursuant to the Purchase Agreement, Pepsi, together with its affiliates, has certain rights and is also subject to various restrictions with respect to the percentage of the Company’s outstanding common shares on an as-converted basis through purchases of the Company’s common stock in the open market and the accumulation of PIK Dividends. Additionally, pursuant to the Purchase Agreement, Pepsi has the right to designate one nominee for election to Company’s board of directors, so long as Pepsi (together with its affiliates) beneficially owns at least approximately 3.7 million shares of the Company’s outstanding common stock on an as-converted basis. In August 2022, the Company expanded the number of seats from eight to nine in connection with the election of a Pepsi representative to the Company’s board of directors. Liquidation Preference The Series A ranks, with respect to distribution rights and rights on liquidation, winding-up and dissolution, (i) senior and in priority of payment to the Company’s common stock, (ii) on parity with any class or series of capital stock of the Company expressly designated as ranking on parity with the Series A, and (iii) junior to any class or series of capital stock of the Company expressly designated as ranking senior to the Series A. The aggregate liquidation preference of the Series A is $550 million as of June 30, 2023 and December 31, 2022. Voting The Series A confers no voting rights, except as otherwise required by applicable law, and with respect to matters that adversely change the powers, preferences, privileges, rights or restrictions given to the Series A or provided for its benefit, or would result in securities that would be senior to or pari passu with the Series A. As described above, Pepsi does have a contractual right to representation on the Company’s Board of Directors, subject to certain shareholdings thresholds. Dividends The Series A entitles the holder to cumulative dividends, which are payable quarterly in arrears either in cash, in-kind, or a combination thereof, at the Company’s election (“Regular Dividends”). Regular Dividends accrue on each share of Series A at the rate of 5.00% per annum, subject to adjustment as set forth in the Series A Certificate. In addition to such quarterly Regular Dividends, shares of Series A also entitle the holder to participate in any dividends paid on the Company’s common stock on an as-converted basis. The Company declared and paid $6.9 million and $13.6 million in Regular Dividends on the Series A, which amounted to $4.67 and $9.30, respectively, per share of Series A for the three and six months ended June 30, 2023. There were no cumulative undeclared dividends on the Series A at June 30, 2023. In addition, there were no dividends issued to common shareholders as of the six months ended June 30, 2023 and 2022. Redemption Pursuant to certain conditions set forth in the Series A Certificate, Series A may be redeemed at a price per share of Series A equal to the sum of (i) the stated value of such share of Series A as of the applicable Redemption Date, plus (ii) without duplication, all accrued and unpaid dividends previously added to the stated value of such share of Series A, and all accrued and unpaid dividends per share of Series A through such Redemption Date (the “Redemption Price”). Company’s Optional Redemption At any time from and after the earlier of (i) August 1, 2029, if the ten-day volume weighted average price of the Company’s common stock (the “Ten-Day VWAP”) does not exceed the conversion price on the date immediately prior to the date the Company delivers a redemption notice to the holders, and (ii) the cancellation of the Distribution Agreement by the Company. The Company shall have the right to redeem all (and not less than all) of the then-outstanding shares of Series A at the Redemption Price. In the event of the Company's optional redemption, the Company shall affect such redemption by paying the entire Redemption Price on or before the date that is thirty days after the delivery of the Company’s redemption notice and by redeeming all the shares of Series A on such date. Change in Control Redemption In the event of (i) a sale or transfer, directly or indirectly, of all or substantially all of the assets of the Company in any transaction or series of related transactions (other than sales in the ordinary course of business); or (ii) any merger, consolidation or reorganization of the Company with or into any other entity or entities as a result of which the holders of the Company’s outstanding capital stock (on a fully-diluted basis) immediately prior to the merger, consolidation or reorganization no longer represent at least a majority of the voting power of the surviving or resulting Company or other entity; or (iii) any sale or series of sales, directly or indirectly, beneficially or of record, of shares of the Company’s capital stock by the holders thereof which results in any person or group of affiliated persons owning capital stock holding more than 50% of the voting power of the Company (a “Change in Control”), the Company (or its successor) shall redeem all (and not less than all) of the then-issued and outstanding shares of Series A. Upon such redemption, the Company will pay or deliver, as applicable, to each holder in respect of each share of Series A held by such holder, an amount equal to the greater of (A) cash in an amount equal to the Redemption Price, or (B) the amount of cash and/or other assets (including securities) such holder would have received had each share of Series A held by such holder as of the close of business on the business day immediately prior to the effective date of such transaction resulting in a Change of Control, converted into a number of shares of common stock equal to the then-applicable conversion ratio and participated in such transaction resulting in such Change of Control as a holder of shares of common stock (such greater amount, the “Change of Control Redemption Price”). If, in connection with a transaction resulting in a Change of Control, the Company or its successor shall not have sufficient funds legally available under the Nevada law governing distributions to stockholders to redeem all outstanding shares of Series A, then the Company shall (A) redeem, pro rata among the holders, a number of shares of Series A equal to the number of shares of Series A that can be redeemed with the maximum amount legally available for the redemption of such shares of Series A under the Nevada law governing distributions to stockholders, and (B) redeem all remaining shares of Series A not redeemed because of the foregoing limitations at the applicable Change of Control Redemption Price as soon as practicable after the Company (or its successor) is able to make such redemption out of assets legally available for the purchase of such share of Series A. The inability of the Company (or its successor) to make a redemption payment for any reason shall not relieve the Company (or its successor) from its obligation to affect any required redemption when, as and if permitted by applicable law. Holder Right to Request Redemption On each of August 1, 2029, August 1, 2032, and August 1, 2035, the majority holders shall have the right, upon no less than six months prior written notice to the Company, to request that the Company redeem all (and not less than all) of the then-outstanding shares of Series A, at the Redemption Price. In the event of a holder optional redemption, the Redemption Price shall be payable, and the shares of Series A redeemed by the Company, in three equal installments, commencing on August 1, 2029, August 1, 2032, or August 1, 2035, as applicable, and in each case on the fifteenth- and thirtieth-month anniversary thereafter (each a "Redemption Date”). On each Redemption Date for a holder optional redemption, the Company shall redeem, on a pro rata basis in accordance with the number of shares of Series A owned by each holder, that number of outstanding shares of Series A determined by dividing (i) the total number of shares of Series A outstanding immediately prior to such Redemption Date by (ii) the number of remaining Redemption Dates (including the Redemption Date to which such calculation applies). If, on any Redemption Date, Nevada law governing distributions to stockholders or the terms of any indebtedness of the Company to banks and other financial institutions engaged in the business of lending money prevent the Company from redeeming all share of Series A to be redeemed, the Company shall ratably redeem the maximum number of shares that it may redeem consistent with such law, and shall redeem the remaining shares as soon as it may lawfully do so under such law. If any shares of Series A scheduled for redemption on a Redemption Date are not redeemed for any reason on such Redemption Date, (x) from such Redemption Date until the fifteen-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to 8% per annum, (y) from such fifteenth-month anniversary of such Redemption Date until the thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to such unredeemed share of Series A shall automatically increase to 10% per annum and (z) from and after such thirtieth-month anniversary of such Redemption Date, the dividend rate with respect to any such unredeemed share of Series A shall automatically increase to 12% per annum, in each case until such share is duly redeemed or converted. Conversion The shares of Series A may be converted into shares of the Company’s common stock pursuant to the Series A Certificate either at the option of the Company or subject to an automatic conversion as discussed below. The Series A was issued with a conversion price of $75 which is potentially subject to adjustment pursuant to the Series A Certificate. The conversion ratio is calculated as the quotient of (a) the sum of (x) the stated value of such share of Series A as of the applicable conversion date, plus (y) of all accrued and unpaid dividends previously added to the stated value of such share of Series A, and without duplication, all accrued and unpaid dividends per share of Series A through the applicable conversion date; divided by (b) the conversion price as of the conversion date. As of June 30, 2023, the conversion ratio of the Series A into common was 1 to 5. At June 30, 2023, approximately 7.3 million shares of the Company’s common stock are issuable upon conversion of the Series A Convertible Preferred Stock. Company Optional Conversion At any time from and after August 1, 2029, provided the Ten-Day VWAP immediately prior to the date the Company delivers a conversion notice to the holders of Series A exceeds the Conversion Price, the Company may elect to convert all, but not less than all, of the outstanding shares of Series A into shares of the Company’s common stock. As of June 30, 2023, the Series A was not probable of becoming redeemable as the most likely method of settlement is through conversion which is likely to occur before the holder's right to request redemption becomes exercisable. Automatic Conversion The Series A will convert automatically into shares of the Company’s common stock upon the occurrence of any of the following, each an “Automatic Conversion Event”: • Any date from and after the valid termination of the Distribution Agreement by the Company or Pepsi, if the Ten-Day VWAP immediately preceding such date exceeds the Conversion Price of such share as of such date. • Any date from and after August 1, 2028, on which (x) the Company’s products meet a market share requirement during a specified period (as defined in the Distribution Agreement) and (y) the Ten-Day VWAP immediately prior to such date exceeds the conversion price of such share as of such date. In the case of an automatic conversion, each share of Series A then outstanding shall be converted into the number of shares of common stock equal to the conversion ratio of such share in effect as of the automatic conversion date. The occurrence of an Automatic Conversion Event will terminate any right of the holder to receive a redemption at their request even if such request has already been submitted, provided that the Series A shares have not already been redeemed Other Accounting Matters The Company has adopted Accounting Standards Update 2020-06 (“ASU 2020-06”), effective January 1, 2022. The provisions of ASU 2020-06 prohibit the recognition of a beneficial conversion feature on preferred shares issued after the adoption of the ASU. The Company adopted ASU 2020-06 for the Preferred Series A for the year ended December 31, 2022. FASB ASC 815 generally requires an analysis of embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. The Company performed an evaluation and determined the Series A and the host instrument is more akin to equity. The Company identified certain embedded redemption and conversion features which it evaluated for bifurcation and determined no bifurcation of these embedded or conversion features was required. |
STOCKHOLDERS_ EQUITY
STOCKHOLDERS’ EQUITY | 6 Months Ended |
Jun. 30, 2023 | |
Equity [Abstract] | |
STOCKHOLDERS' EQUITY | STOCKHOLDERS’ EQUITY Issuance of common stock pursuant to exercise of stock options and other awards During the six months ended June 30, 2023, the Company issued an aggregate of 0.5 million shares of its common stock pursuant to the exercise grants under the Company’s 2015 Plan. The Company received aggregate proceeds of approximately $0.7 million for 0.2 million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis. During the six months ended June 30, 2022, the Company issued an aggregate of 0.7 million shares of its common stock pursuant to the exercise grants under the Company's 2015 Plan. The Company received aggregate proceeds of approximately $1.3 million for 0.4 million options exercised for cash, with the balance of the options having been exercised on a “cashless” basis. |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Measurements, Nonrecurring Value Measurement [Abstract] | |
FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below: Level 1: Observable inputs such as quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions. The Company engaged a third-party valuation firm to assist in determining the fair value of the approximately 1.5 million shares of Series A Convertible Preferred Stock issued on August 1, 2022. The Series A Convertible Preferred Stock is classified in mezzanine equity, see Note 14. Mezzanine Equity for more information . Mezzanine equity and the valuation of the Series A Convertible Preferred Stock represents a non-recurring fair value measurement. The Company used a Monte Carlo simulation model to determine the fair value of the Series A Convertible Preferred Stock on August 1, 2022. The Monte Carlo simulation utilized multiple input variables to determine the value of the Series A Convertible Preferred Stock including a volatility rate of 45%, risk free interest rate of 2.69%, 5.0% dividend rate, the closing price of the Company’s common stock on the issuance date of $98.87, a debt discount rate of 12.5% and a discount for lack of marketability attributed to the registration period of the underlying stock. The selected historical volatility was based on Celsius and a certain peer group. The risk-free interest rate was based on the US STRIPS Rate with a corresponding term as of issuance date. The 5.0% dividend rate is consistent with the provisions of the Series A Convertible Preferred Stock and with the Company’s past payments made in cash. The debt discount rate was based on estimated credit analysis and corresponding market yields as of the issuance date. The Company applied a nominal discount for lack of marketability with respect to the assumed registration period of the underlying shares. The following is a tabular presentation of the non-recurring fair value measurement along with the level within the fair value hierarchy: June 30, 2023 Level 1 Level 2 Level 3 Mezzanine equity: Series A convertible preferred shares $ — $ 824,488 $ — Total $ — $ 824,488 $ — Other than those noted previously, the Company did not have any other assets or liabilities measured at fair value at June 30, 2023 and December 31, 2022. |
INCOME TAXES
INCOME TAXES | 6 Months Ended |
Jun. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES In general, the Company uses an estimated annual effective tax rate, which is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in which they occur and can be a source of variability on the effective tax rates from quarter to quarter. The Company’s effective tax rate may change from period to period based on recurring and non-recurring factors including the geographical mix of earnings, enacted tax legislation, and state and local income taxes. The effective income tax rate for the three months ended June 30, 2023 was 25.8%, and differed from the statutory federal income tax rate of 21.0% primarily due to disallowed stock-based compensation expense and state income taxes. The effective income tax rate for the six months ended June 30, 2023 was 22.2%, and differed from the statutory federal income tax rate of 21.0% primarily due to windfall benefits on stock-based compensation awards, disallowed stock-based compensation expense, and state income taxes. The effective income tax rate for the three months ended June 30, 2022 was 23.5%, and differed from the statutory federal income tax rate of 21.0% primarily due to the impact of disallowed stock-based compensation expense, state income tax expense, and the release of certain state income tax reserves. The effective income tax rate for the six months ended June 30, 2022 was 28.0%, and differed from the statutory federal income tax rate of 21.0% primarily due to the impact of disallowed stock-based compensation expense, state income tax expense, and the release of certain state income tax reserves. The Company is subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. The Company recognizes those tax positions that meet the more-likely-than-not recognition threshold and establishes tax reserves for uncertain tax positions that do not meet this threshold. Interest and penalties associated with income tax matters are included in the provision for income taxes in the consolidated statements of operations and comprehensive income. |
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION | 6 Months Ended |
Jun. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION The Company adopted the 2006 Incentive Stock Plan on January 18, 2007. This plan was intended to provide incentives to attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. While the plan terminated 10 years after the adoption date, issued awards have their own schedule of terminations. The Company is no longer granting awards under this plan and there are no unvested awards as of June 30, 2023. The Company adopted the 2015 Plan on April 30, 2015. The 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock or to receive monetary payments based on the value of such shares pursuant to awards issued. The 2015 Plan permits the grant of options and shares for up to 5 million shares. In addition, there is a provision in the 2015 Plan for an annual increase to the maximum number of shares authorized under the 2015 Plan. The increase shall be added on the first day of the calendar year beginning January 1, 2016, equal to 15% of the number of shares outstanding as of such date. As of June 30, 2023, approximately 5.9 million shares are available for issuance under the 2015 Plan. See Note 15 Stockholders' Equity for more information. For the three months ended June 30, 2023 and 2022, the Company recognized an expense of approximately $5.7 million and $4.2 million, respectively. For the six months ended June 30, 2023 and 2022, the Company recognized an expense of approximately $11.2 million and $8.5 million, respectively, of non-cash compensation expense (included in selling, general and administrative expense in the accompanying consolidated statements of operations and comprehensive income). Stock Options The Company used straight-line amortization of compensation expense over the two The Company uses the Black-Scholes option-pricing model to estimate the fair value of its stock option awards and warrant issuances and recognizes forfeitures as they occur. The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: 2023 (1) 2022 (1) 2021 Expected volatility NA NA 69.18 - 81.11% Expected term NA NA 4.49 - 5.00 Years Risk-free interest rate NA NA 0.32% - 1.39% Forfeiture Rate NA NA 0.0% (1) No stock options were issued for the six months ended June 30, 2023 and the year ended December 31, 2022. A summary of the status of the Company’s outstanding stock options as of June 30, 2023 and changes during the six months ending on that date is as follows: Weighted Average Aggregate Weighted Shares Exercise Grant Date At December 31, 2022 2,266 $ 9.66 $ 213,914 5.43 Granted Exercised (290) 5.20 102.03 28,070 Forfeiture and cancelled (1) 18.17 At June 30, 2023 1,975 $ 10.31 $ 274,461 4.68 Exercisable at June 30, 2023 1,850 $ 8.47 $ 260,268 4.49 The following table summarizes information about employee stock options outstanding at June 30, 2023: Outstanding Options Vested Options Range of Exercise Price Number Outstanding at June 30, 2023 (000's) Weighted Average Remaining Life Weighted Average Exercise Price Number Exercisable at June 30, 2023 (000's) Weighted Average Exercise Price Weighted Average Remaining Life $0.34 - $1.05 30 0.94 $ 0.58 30 $ 0.58 0.94 $1.97 - $2.96 5 2.52 1.97 5 1.97 2.52 $3.23 - $4.85 1,377 4.01 3.81 1,378 3.81 4.01 $5.59 - $8.39 188 4.76 5.78 189 5.78 4.76 $14.53 - $21.80 60 7.09 14.53 40 14.53 7.09 $21.80 - $32.70 14 7.17 21.80 8 21.80 7.04 $42.64 - $63.96 301 7.51 42.67 200 42.67 7.51 Outstanding options 1,975 4.68 $ 10.31 1,850 $ 8.47 4.49 As of June 30, 2023 and 2022, the Company had approximately $1.6 million and $5.5 million, respectively, of unrecognized pre-tax non-cash compensation expense related to options to purchase shares, which the Company expects to recognize, based on a weighted-average period of 0.5 years. Restricted Stock Awards Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holders of a restricted stock award are generally entitled after the release to transact and obtain the same rights as the rights of a shareholder of the Company, including the right to vote the shares. The holders of unvested restricted stock awards do not have the same rights as shareholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock awards that vest over time is established by the market price on the date of its grant. The Company determines the fair value of restricted stock-based awards based on the market price on the date of grant. A summary of the Company’s restricted stock award activity for the six months ended June 30, 2023 and 2022 is presented in the following table: Six Months Ended June 30, 2023 June 30, 2022 Shares Weighted Shares Weighted Unvested at beginning of period — $ — 0.2 $ 14.72 Transfers to restricted stock units — — — — Granted — — — — Vested — — — — Forfeited and cancelled — — (0.2) $ 14.72 Unvested at end of period — $ — — $ — There were no restricted stock awards granted, vested or outstanding during the six months ended June 30, 2023. Fair value of shares vested during the six months ended June 30, 2023 and 2022 was immaterial. There was no unrecognized compensation expense related to outstanding restricted stock awards to employees and directors for the six months ended June 30, 2023 and 2022. Restricted Stock Units Restricted stock units are awards that give the holder the right to receive one share of common stock for each restricted stock unit upon meeting service-based vesting conditions (typically annual vesting in three equal annual installments, with a requirement that the holder remains in the continuous employment of the Company). The Company determines the fair value of restricted stock-based awards based on the market price on the date of grant. The holders of unvested units do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. The value of restricted stock units that vest over time is established by the market price on the date of its grant. A summary of the Company’s restricted stock unit activity for the six months ended June 30, 2023 and 2022 is presented in the following table: Six Months Ended June 30, 2023 June 30, 2022 Shares (000's) Weighted Shares (000's) Weighted Unvested at beginning of period 539 $ 60.73 566 $ 52.66 Transfers to restricted stock awards — — — — Granted 136 103.19 202 73.33 Vested (196) 57.30 (145) 51.08 Forfeited and cancelled (42) 67.72 (42) 61.17 Unvested at end of period 437 $ 74.79 581 $ 59.62 The total fair value of shares vested during the six months ended June 30, 2023 and 2022 was approximately $20.5 million and $7.4 million, respectively. Unrecognized compensation expense related to outstanding restricted stock units to employees and directors as of June 30, 2023 and 2022 was $24.0 million and $25.8 million, respectively, and is expected to be expensed over the next 2.0 years. Performance-based Stock Awards The Company issued stock-based awards to third-party consultants for providing marketing, sales, and general business development services related to Celsius products. The stock-based awards are in the form of restricted stock units with performance vesting conditions (“performance stock units” or “PSUs”). The holders of unvested PSUs do not have the same rights as stockholders including but not limited to any dividends which may be declared by the Company, and do not have the right to vote. Some of the PSU performance vesting conditions are linked to the consultants obtaining specified incremental earnings for the Company in a given year over the performance vesting period (typically five years) and some of the awards are linked to employees of the Company and have specific performance-based metrics to be met in year one and year two of the issuance. The fair value of PSUs is based on the market price of the underlying stock on the grant date. The Company recognizes compensation cost for performance stock awards issued to non-employees in the same manner and periods as though cash had been paid for services received. In the third quarter of 2022, the Human Resources and Compensation Committee of the Board of Directors approved the issuance of PSUs to certain employees which represented restricted share units with performance-based vesting. The aggregate grant date fair value of $7.5 million included an immediate vesting of 20% of the shares as well as specific performance-based metrics to be met in year one and year two of the issuance. The Company believes the performance-based metrics are probable of being achieved and will recognize expense for each tranche of the awards separately using the accelerated attribution method according to ASC 718. A summary of the Company’s PSU activity for the six months ended June 30, 2023 and 2022 is presented in the following table: Six Months Ended June 30, 2023 June 30, 2022 Shares (000's) Weighted Shares (000's) Weighted Unvested at beginning of period 76 $ 91.48 15 $ 64.65 Granted — — — — Vested — — — — Forfeited and cancelled — — — — Unvested at end of period 76 $ 91.48 15 $ 64.65 Unrecognized compensation expense related to outstanding PSUs issued to employees and non-employee consultants as of June 30, 2023 and 2022 was approximately $2.1 million and $0.8 million, respectively, and is expected to be expensed over the next 1.1 years. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 6 Months Ended |
Jun. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES Legal On January 8, 2021, the Company received a letter from the SEC Division of Enforcement seeking the production of documents in connection with a non-public fact-finding inquiry by the SEC to determine whether violations of the federal securities laws had occurred. The Company has subsequently, received subpoenas for the production of documents in connection with this matter. The investigation and requests from the SEC do not represent that the SEC has concluded that the Company or anyone else has violated the federal securities laws. The Company has cooperated and will continue to cooperate with the SEC staff in its investigation and requests. At this time, however, the Company cannot predict the length, scope, or results of the investigation or the impact, if any, of the investigation on the Company's results of operations. On March 16, 2022, a class action lawsuit was filed against the Company in the United States District Court for the Southern District of Florida. Plaintiffs asserted the Company's delay in filing its Annual Report on Form 10-K for the year ended December 31, 2021, caused a decline in the market value of the Company’s securities and as a result, class members suffered significant losses and damages. On June 6, 2022, Judge Middlebrooks appointed a lead class plaintiff and the Company filed its motion to dismiss on August 5, 2022. On March 22, 2023, the motion to dismiss was granted in part and denied in part, and discovery has commenced with anticipated summary judgment motions later this year. As the Company has previously disclosed in its periodic reports filed with the SEC, prior to filing an application for an automatic 15 day extension of the original filing date, the Company experienced staffing limitations, unanticipated delays and identified material errors in previous filings. The Company does not believe it has committed any federal securities violations or made false and/or misleading statements and/or material omissions as alleged in the complaint and had strong defenses. However, to avoid the uncertainty of litigation, the Company decided to settle the lawsuit and reached a nationwide class settlement in principle with the plaintiffs on July 17, 2023 for $7.9 million. The full amount of the settlement has been accrued as of June 30, 2023, within accounts payable and accrued expenses, in the consolidated balance sheets. On January 11, 2023, Doreen R. Lampert filed a derivative stockholder complaint against certain of the Company’s directors and a former officer and, nominally, against the Company, in the United States District Court of the District of Nevada. Plaintiff Lampert asserts that the same allegations giving rise to the class action lawsuit discussed in the preceding paragraph also supported claims for breach of fiduciary duty against the directors and former officer, among other claims. The deadline to respond to the complaint was to be April 20, 2023. The parties agreed to stay this action pending the close of discovery in the class action lawsuit. On May 19, 2023, a similar derivative stockholder complaint was filed in the United States District Court for the District of Florida, with substantially similar allegations to the derivative action filed in Nevada. The parties agreed to stay this action pending the close of discovery in the class action lawsuit. On July 10, 2023, another similar derivative stockholder complaint was filed in the Clark County District Court, State of Nevada, with substantially similar allegations to the derivative action filed in Nevada, and on July 12, 2023, a fourth similar derivative stockholder complaint was filed in the United States District Court for the District of Florida, with substantially similar allegations to the derivative action filed in Nevada. On July 17, 2023, the Company, along with the plaintiffs of the case being held in the United States District Court for the Southern District of Florida, informed the court that they had reached a tentative agreement to resolve the action on a class-wide basis. The preliminary agreement entails a one-time cash payment of $7.9 million in return for dismissing all allegations leveled against the defendants. However, this agreement is still contingent on final documentation, judicial endorsement, and the fulfillment of other conditions. On May 4, 2021, Plaintiffs Strong Arm Productions USA, Inc., Tramar Dillard p/k/a Flo Rida, and D3M Licensing Group, LLC filed a lawsuit against the Company in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida. Plaintiffs asserted that the Company breached two endorsement and licensing agreements that were entered into, between Plaintiffs and the Company in 2014 and 2016. Plaintiffs alleged the Company had reached certain revenue and sales benchmarks set forth in the 2014 agreement that entitled them to receive 750,000 shares of the Company's common stock. In addition, Plaintiffs claimed they were entitled to receive unspecified royalties under the 2016 agreement. A jury trial commenced on this matter on January 10, 2023. On January 18, 2023, the jury rendered a verdict against the Company for $82.6 million in compensatory damages. On April 27, 2023, the court denied the Company’s post-trial motions which sought (i) judgment in favor of the Company dismissing the case notwithstanding the verdict based on the plain language of the contracts at issue; (ii) in the alternative, granting a new trial due to the numerous errors at trial; or (iii) in the alternative, reducing the award of damages to $2.1 million, which reflects the Company’s stock price on the date that the jury found the relevant revenue and sales benchmarks at issue were met. The judgment will accrue post-judgement interest at 5.52% per year commencing February 13, 2023. The Company believes that the jury verdict is not supported by the facts of the case or applicable law, is the result of significant trial error, and there are strong grounds for appeal. The Company filed a notice of appeal to the Fourth District Court of Appeal for the State of Florida on February 21, 2023, which is currently proceeding. The Company intends to vigorously challenge the judgment through the appeal processes. As a result, the Company believes that the likelihood that the amount of the judgment will be affirmed is not probable. The Company has taken into consideration the events that have occurred after the reporting period and before the financial statements were issued. The Company currently estimates a range of possible outcomes between $2.1 million and $82.6 million plus interest, and the Company has accrued a liability as of June 30, 2023 and December 31, 2022, reflected in accounts payable and accrued expenses in the consolidated balance sheets, at the low end of the range. The ultimate loss to the Company of the litigation matter could be materially different from the amount the Company has accrued. The Company cannot predict or estimate the duration or ultimate outcome of this matter. In addition to the foregoing, from time to time, the Company may become party to litigation or other legal proceedings that is considered to be a part of the ordinary course of business. Commitments The Company has entered into distribution agreements with liquidated damages in case the Company cancels the distribution agreements without cause. Cause has been defined in various ways. If management makes the decision to terminate an agreement without cause, an estimate of expected damages is accrued, and an expense is recorded within selling, general and administrative expenses in the consolidated statements of operations and comprehensive income during the period in which termination was initiated. As of June 30, 2023 and December 31, 2022, the Company had contingent commitments to third parties of $75.4 million and $30.7 million, respectively. The Company's guarantees are primarily related to third party suppliers and have arisen through the normal course of business. The contingent commitments may have various terms, and none are individually significant. The Company had contractual obligations aggregating approximately $3.9 million at June 30, 2023, which related primarily to sponsorships and other marketing activities. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 6 Months Ended |
Jun. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date the consolidated financial statements are issued. Except for the matters discussed in Note 19. Commitments and Contingencies , there were no other subsequent events that would have required adjustment or disclosure in the consolidated financial statements. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Pay vs Performance Disclosure | ||||
Net Income (Loss) | $ 51,509 | $ 9,158 | $ 92,736 | $ 15,838 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
BASIS OF PRESENTATION AND SUM_2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation — The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and notes required by US GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. The results for the three and six months ended June 30, 2023 are not necessarily indicative of the results expected for any future period or the full year. These unaudited consolidated financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and the Amendment No. 1 to the Annual Report on Form 10-K/A (collectively the "2022 Annual Report"). These unaudited consolidated financial statements and the accompanying notes should be read in conjunction with the 2022 Annual Report. The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Certain prior period amounts have been reclassified to conform with current period presentation in the consolidated financial statements and notes thereto. Accrued promotional allowance and income tax payable were reallocated from within Accounts payable and accrued expenses and are now reflected as standalone line items in the consolidated balance sheets and consolidated statements of cash flows, respectively. |
Significant Estimates | Significant Estimates — The preparation of consolidated financial statements and accompanying disclosures in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include the allowance for current expected credit losses, allowance for inventory obsolescence and sales returns, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred taxes and related valuation allowance, promotional allowance, and valuation of stock-based compensation. |
Segment Reporting | Segment Reporting — Operating segments are defined as components of an enterprise that engage in business activities, have discrete financial information, and whose operating results are regularly reviewed by the chief operating decision maker ("CODM") to make decisions about allocating resources and to assess performance. Even though the Company has operations |
Concentrations of Risk | Concentrations of Risk — Substantially all of the Company’s revenue is derived from the sale of Celsius® functional energy drinks and liquid supplements. Revenue from customers accounting for more than 10% of total revenue for the three and six months ended June 30, 2023 and 2022 are as follows: For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 Pepsi 56.7 % — % 58.3 % — % Costco 13.0 % 15.9 % 12.9 % 16.6 % All others 30.3 % 84.1 % 28.8 % 83.4 % Total 100.0 % 100.0 % 100.0 % 100.0 % Accounts receivable from customers accounting for more than 10% of total accounts receivable for the six months ended June 30, 2023 and the year ended December 31, 2022 are as follows: 2023 2022 Pepsi 68.4 % 47.6 % Amazon 10.7 % 11.8 % All others 20.9 % 40.6 % Total 100.0 % 100.0 % Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and note receivable. The Company places its cash and cash equivalents with high-quality financial institutions. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation limit. At June 30, 2023 and December 31, 2022, the Company had approximately $680.6 million and $652.4 million in excess of the Federal Deposit Insurance Corporation limit. |
Cash Equivalents | Cash Equivalents — The Company considers all highly liquid instruments with original maturities of three months or less when purchased to be cash equivalents. At June 30, 2023 and December 31, 2022, the Company did not have any investments with original maturities of three months or less. |
Restricted Cash | Restricted Cash — The Company received upfront payments from Pepsi during 2022, which were contractually restricted and could only be used to satisfy termination payments due to former distributors or must be repaid to Pepsi. These upfront payments received from Pepsi could not be used for general operating activities of the Company and were classified as restricted cash based on the terms of the Transition Agreement. See Note 4. Revenue for more information. At June 30, 2023, the Company did not have restricted cash. At December 31, 2022, the Company had $38.8 million of restricted cash. |
Accounts Receivable and Current Expected Credit Losses | Accounts Receivable and Current Expected Credit Losses — The Company is exposed to potential credit risks associated with its product sales and related accounts receivable, as it generally does not require collateral. The Company’s expected loss allowance methodology for accounts receivable is developed using historical collection experience, current and future economic and market conditions, a review of the current status of customers’ trade accounts receivables, and where available, a review of the financial strength and credit ratings of larger customers. Customers are pooled based on sharing specific risk factors and the Company reassesses these customer pools on a periodic basis. The receivables allowance is based on aging of the accounts receivable balances and forward-looking information. The Company uses the probability of default and forward-looking information to assess credit risk and estimate expected credit losses for its note receivable related to Qifeng Food Technology (Beijing) Co. Ltd ("Qifeng"). See Note 7. Note Receivable for more information on Qifeng and the note receivable. |
Inventories | Inventories — Inventories are valued at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. |
Property and Equipment | Property and Equipment — Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful life of the asset, generally ranging from three |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets — In accordance with ASC Topic 360, Property, Plant, and Equipment the Company reviews the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss is determined regarding a long-lived asset, if its carrying amount is not recoverable and exceeds its fair value. The carrying amount is not recoverable when it exceeds the sum of the undiscounted cash flows expected to result from use of the asset over its remaining useful life and final disposition. The Company did not record any impairment charges during the six months ended June 30, 2023 and 2022. |
Goodwill | Goodwill — The Company records goodwill when the consideration paid for an acquisition exceeds the fair value of net tangible and intangible assets acquired, including related tax effects. Goodwill is not amortized; instead, goodwill is tested for impairment on an annual basis as of October 1st, or more frequently if the Company believes indicators of impairment exist. The Company first assesses qualitative factors such as macro-economic conditions, industry and market conditions, and cost factors as well as other relevant events, to determine whether it is more-likely-than-not that the fair value of a reporting unit is less than its carrying value. If the Company determines that the fair value is less than the carrying value, the Company will recognize an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. |
Intangible assets | Intangible Assets — Intangible assets are comprised of customer relationships and brands acquired in a business combination. In accordance with ASC Topic 350, Intangibles - Goodwill, and Other, the Company amortizes intangible assets with a definitive life over their respective useful lives. The Company tests intangible long-lived assets for impairment when events suggest that the carrying amount may not be recoverable. The test involves comparing the asset's carrying amount to its estimated undiscounted future cash flows. If the carrying amount exceeds these cash flows, an impairment loss, equal to the difference between the carrying amount and the fair value, is recognized. Assets with indefinite lives are tested for impairment |
Revenue Recognition | Revenue Recognition — The Company recognizes revenue in accordance with ASC Topic 606 Revenue from Contracts with Customers ("ASC 606"). Revenue is recognized when performance obligations under the terms of a contract with the customer are satisfied. Product sales occur once control is transferred based on the commercial terms of the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods. See Note 4. Revenue for more information. |
Deferred Revenue and Shipping and Handling Costs | Deferred Revenue — The Company receives payments from certain distributors in new territories as reimbursement for contract termination costs paid to the prior distributors in those territories. Amounts received pursuant to these new and/or amended distribution agreements entered into with certain distributors relating to the costs associated with terminating the Company’s prior distributors, are accounted for as deferred revenue and recognized ratably over the anticipated life of the respective new distribution agreements. Shipping and Handling Costs — Shipping and handling costs for freight expense on goods shipped are included in cost of revenue. |
Accrued distributor termination fees | Accrued Distributor Termination Fees — Termination charges related to certain of the Company’s prior distributors are included in selling and marketing expenses upon termination. The Company did not have any accrued distributor termination fees as of June 30, 2023. Refer to Note 13. Related Party Transactions |
Customer Advances | Customer Advances — From time to time the Company requires deposits in advance of delivery of products and/or production runs. Such amounts are initially recorded as customer advances liability within deferred revenue. The Company recognizes such revenue as it is earned in accordance with revenue recognition policies. The Company had no customer advances as of June 30, 2023 or December 31, 2022, respectively. |
Advertising Costs | Advertising Costs — Advertising costs are expensed as incurred and charged to selling, general and administrative expenses. The Company mainly uses radio, local sampling events, sponsorships, endorsements, and digital advertising. |
Research and Development | Research and Development — Research and development costs are charged to selling, general and administrative expenses as incurred and consist primarily of consulting fees, raw material usage and test productions of beverages. |
Foreign Currency Gain/Losses | Foreign Currency Gain/Loss — Foreign subsidiaries’ functional currency is the local currency of operations and the net assets of foreign operations are translated into U.S. dollars using current exchange rates. The foreign subsidiaries perform re-measurements of their assets and liabilities denominated in non-functional currencies on a periodic basis and the gain or losses from these adjustments related to fluctuations in foreign exchange rates versus the U.S. dollar are included in the Statements of Operations as foreign exchange gains or losses. For the three months ended June 30, 2023 exchange loss was approximately $0.9 million versus foreign exchange loss of approximately $0.5 million during the three months ended June 30, 2022. For the six months ended June 30, 2023, the foreign exchange loss was approximately $1.0 million versus approximately $0.7 million during the six months ended June 30, 2022. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments — The carrying value of cash and cash equivalents, accounts receivable, accounts payable, other current liabilities, note receivable and accrued expenses approximate fair value due to their relative short-term maturity and market interest rates. |
Income Taxes | Income Taxes — The Company accounts for income taxes pursuant to the provisions of ASC Topic 740-10, Accounting for Income Taxes ("ASC 740-10"), which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more-likely-than-not that the net deferred asset will not be realized. The Company follows the provisions of the ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more-likely-than-not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50% likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company affirms a tax position as effectively settled upon the completion of an examination by a taxing authority, irrespective of whether the position has been legally extinguished, as per ASC 740-10-25 Definition of Settlement . By doing so, the Company ensures the recognition of previously unrecognized tax benefits. This policy allows the Company to record the full amount of tax benefit related to each tax position, even in cases where, based solely on its technical merits, the tax position is not seen as more-likely-than-not to be sustained and the statute of limitations remains open. The Company’s tax returns for tax years in 2020 through 2022 remain subject to potential examination by the taxing authorities. |
Earnings per Share | Earnings per Share — The Company computes earnings per share in accordance with ASC Topic 260 Earnings per Share (“ASC 260”), which requires earnings per share ("EPS") for each class of stock (common stock and participating preferred stock) to be calculated using the two-class method. The two-class method is an allocation of earnings (distributed and undistributed) between the holders of common stock and a company’s participating preferred stockholders. Under the two-class method, earnings for the reporting period are allocated between common stockholders and other security holders based on their respective participation rights in undistributed earnings. See Note 3. Earnings per Share for more information. |
Share-Based Payments | Stock-Based Compensation — The Company follows the provisions of ASC Topic 718 Compensation — Stock Compensation and related interpretations. As such, compensation cost is measured on the date of grant at the fair value of the stock-based compensation. Such compensation amounts, if any, are amortized over the respective vesting periods of the grants. On April 30, 2015, the Company adopted the 2015 Stock Incentive Plan (the "2015 Plan"). This 2015 Plan is intended to provide incentives which will attract and retain highly competent persons at all levels as employees of the Company, as well as independent contractors providing consulting or advisory services to the Company, by providing them opportunities to acquire the Company’s common stock. The 2015 Plan permits the grant of options and other stock-based awards for up to 5 million shares. In addition, there is a provision for an annual increase of 15% to the shares included under the plan, with the shares to be added on the first day of each calendar year, beginning on January 1, 2016. See Note 18. Stock-Based Compensation for more information. |
Cost of Revenue | Cost of Revenue — Cost of Revenue consists of the cost of concentrates and or liquid bases, the costs of raw materials utilized in the manufacturing of products, co-packing fees, repacking fees, in-bound & out-bound freight charges, as well as certain internal transfer costs, warehouse expenses incurred prior to the manufacturing of the Company’s finished products, inventory allowance for excess and obsolete products, and certain quality control costs. Raw materials account for the largest portion of the cost of revenue. Raw materials include cans, bottles, other containers, flavors, ingredients, and packaging materials. |
Operating Expenses | Operating Expenses — Operating expenses include selling expenses such as warehousing expenses after manufacturing, as well as expenses for advertising, samplings and in-store demonstrations, costs for merchandise displays, point-of-sale materials and premium items, sponsorship expenses, other marketing expenses and design expenses. Operating expenses also includes costs such as payroll costs, travel costs, professional service fees (including legal fees), depreciation and other general and administrative costs. These expenses are included in selling, general and administrative expenses in the consolidated statements of operations and comprehensive income. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company adopts all applicable, new accounting pronouncements as of the specified effective dates. Effective January 1, 2023, the Company adopted ASU 2016-13 Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("CECL") , |
BASIS OF PRESENTATION AND SUM_3
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Revenue and Accounts Receivable with Customers | Revenue from customers accounting for more than 10% of total revenue for the three and six months ended June 30, 2023 and 2022 are as follows: For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 Pepsi 56.7 % — % 58.3 % — % Costco 13.0 % 15.9 % 12.9 % 16.6 % All others 30.3 % 84.1 % 28.8 % 83.4 % Total 100.0 % 100.0 % 100.0 % 100.0 % Accounts receivable from customers accounting for more than 10% of total accounts receivable for the six months ended June 30, 2023 and the year ended December 31, 2022 are as follows: 2023 2022 Pepsi 68.4 % 47.6 % Amazon 10.7 % 11.8 % All others 20.9 % 40.6 % Total 100.0 % 100.0 % |
Schedule of Allowance for Exepected Credit Losses | Allowance for Expected Credit Losses Balance as of December 31, 2022 $ 2,147 Current period change for expected credit losses (118) Balance as of June 30, 2023 $ 2,029 |
Schedule of Long-Lived Assets by Geographic Areas | The following table sets forth long-lived asset information, which includes property and equipment-net, right-of-use assets, and definite-lived intangibles and excludes goodwill and indefinite-lived intangibles, where individual countries represent a significant portion of the total: June 30, December 31, United States $ 15,042 $ 9,750 Finland 12,165 12,171 Sweden 1,338 1,251 Other 29 1 Long-lived assets related to foreign operations 13,532 13,423 Total long-lived assets-net $ 28,574 $ 23,173 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | Under the two-class method of calculating diluted earnings per share, net income is reallocated to common stock, the Series A Convertible Preferred Stock, and all dilutive securities based on the contractual participating rights of the security to share in the current earnings as if all of the earnings for the period had been distributed. For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 Numerator: Net income $ 51,509 $ 9,158 $ 92,736 $ 15,838 Less: dividends paid to Series A convertible preferred stockholders (6,856) — (13,637) — Undistributed income 44,653 9,158 79,099 15,838 Income allocated to participating preferred shares (3,796) — (6,727) — Net income attributable to common stockholders $ 40,857 $ 9,158 $ 72,372 $ 15,838 Denominator: Weighted average basic common shares outstanding 76,845 75,451 76,759 75,472 Dilutive effect of common shares 2,099 2,921 2,100 2,925 Weighted average diluted shares outstanding 78,944 78,372 78,859 78,397 Earnings per share: Basic $ 0.53 $ 0.12 $ 0.94 $ 0.21 Dilutive $ 0.52 $ 0.12 $ 0.92 $ 0.20 |
REVENUE (Tables)
REVENUE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Revenue [Abstract] | |
Schedule of Net Sales by Reporting Segment | Information about the Company’s net sales by geographical location for the three and six months ended June 30, 2023 and 2022 is as follows: For The Three Months Ended June 30, For The Six Months Ended June 30, 2023 2022 2023 2022 North America $ 310,815 $ 145,409 $ 559,367 $ 268,882 Europe 11,909 7,280 20,561 15,775 Asia-Pacific 1,606 883 2,864 1,849 Other 1,553 448 3,030 902 Net sales $ 325,883 $ 154,020 $ 585,822 $ 287,408 |
INVENTORIES (Tables)
INVENTORIES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventories | Inventories, net consist of the following: June 30, December 31, Finished goods $ 95,766 $ 119,229 Raw materials 61,322 62,491 Less: Inventory reserve (4,543) (8,431) Inventories-net $ 152,545 $ 173,289 |
NOTE RECEIVABLE (Tables)
NOTE RECEIVABLE (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Note Receivable [Abstract] | |
Schedule of Note Receivable | Note receivable consists of the following: June 30, December 31, Note receivable-current $ 3,392 $ 2,979 Current period change for expected credit losses (1) (69) — Note receivable-non-current — 3,574 Total $ 3,323 $ 6,553 (1) Upon adoption of CECL in Q1 2023, the Company recorded a reserve for estimated expected credit losses associated with the note receivable. |
LEASES (Tables)
LEASES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Disclosure Leases [Abstract] | |
Schedule of Future Minimum Lease Payments | The future annual minimum lease payments required under the Company’s operating and finance lease liabilities as of June 30, 2023 are as follows: Future minimum lease payments Operating Finance Total 2023 $ 334 $ 52 $ 386 2024 369 40 409 2025 54 68 122 2026 31 65 96 2027 — — — Total future minimum lease payments 788 225 1,013 Less: Amount representing interest (34) (11) (60) Present value of lease liabilities 754 214 953 Less: current portion (505) (67) (674) Long-term portion $ 249 $ 147 $ 279 |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property and Equipment | Property and equipment-net consists of the following: Estimated Useful Life in Years June 30, December 31, Merchandising equipment - coolers 3-7 $ 14,962 $ 9,885 Office equipment 3-7 1,286 1,124 Vehicles 5 2,596 1,257 Less: accumulated depreciation (2,952) (2,081) Total $ 15,892 $ 10,185 |
GOODWILL AND INTANGIBLES (Table
GOODWILL AND INTANGIBLES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Accumulated Amortization of Intangible Assets | The carrying amount and accumulated amortization of intangible assets as of June 30, 2023 and December 31, 2022, respectively, were as follows: June 30, December 31, Definite-lived intangible assets Customer relationships $ 13,670 $ 13,418 Less: accumulated amortization (1,914) (1,610) Definite-lived intangible assets, net $ 11,756 $ 11,808 Indefinite-lived intangible assets Brands $ 446 $ 2,984 Less: impairment — (2,576) Effect of exchange rate changes 9 38 Indefinite-lived intangible assets, net $ 455 $ 446 Intangibles-net $ 12,211 $ 12,254 |
Schedule Future Estimated Amortization Expense | The following is the future estimated annualized amortization expense related to customer relationships: 2023 $ 273 2024 547 2025 547 2026 547 2027 547 Thereafter 9,295 Total $ 11,756 |
ACCOUNTS PAYABLE AND ACCRUED _2
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Accounts Payable and Accrued Expenses | Accounts payable and accrued expenses consist of the following: June 30, December 31, Accounts payable $ 26,039 $ 36,248 Due to Pepsi (1) — 34,807 Accrued freight 4,472 8,532 Accrued expenses 31,514 7,425 Accrued legal 12,403 10,463 Unbilled purchases 19,885 8,672 Total $ 94,313 $ 106,147 (1) See Note 13. Related Party Transactions for more information related to Pepsi. |
OTHER CURRENT LIABILITIES (Tabl
OTHER CURRENT LIABILITIES (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Other Current Liabilities | Other current liabilities consist of the following: June 30, December 31, VAT payable $ 591 $ 198 State Beverage Container Deposit 6,518 3,388 Total $ 7,109 $ 3,586 |
FAIR VALUE MEASUREMENTS (Tables
FAIR VALUE MEASUREMENTS (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Fair Value Measurements, Nonrecurring Value Measurement [Abstract] | |
Summary of Preferred Shares | The following is a tabular presentation of the non-recurring fair value measurement along with the level within the fair value hierarchy: June 30, 2023 Level 1 Level 2 Level 3 Mezzanine equity: Series A convertible preferred shares $ — $ 824,488 $ — Total $ — $ 824,488 $ — |
STOCK-BASED COMPENSATION (Table
STOCK-BASED COMPENSATION (Tables) | 6 Months Ended |
Jun. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule Valuation Assumptions | The calculation of the fair value of the awards using the Black-Scholes option-pricing model is affected by the Company’s stock price on the date of grant as well as assumptions regarding the following: 2023 (1) 2022 (1) 2021 Expected volatility NA NA 69.18 - 81.11% Expected term NA NA 4.49 - 5.00 Years Risk-free interest rate NA NA 0.32% - 1.39% Forfeiture Rate NA NA 0.0% (1) No stock options were issued for the six months ended June 30, 2023 and the year ended December 31, 2022. |
Schedule of Outstanding Stock Options | A summary of the status of the Company’s outstanding stock options as of June 30, 2023 and changes during the six months ending on that date is as follows: Weighted Average Aggregate Weighted Shares Exercise Grant Date At December 31, 2022 2,266 $ 9.66 $ 213,914 5.43 Granted Exercised (290) 5.20 102.03 28,070 Forfeiture and cancelled (1) 18.17 At June 30, 2023 1,975 $ 10.31 $ 274,461 4.68 Exercisable at June 30, 2023 1,850 $ 8.47 $ 260,268 4.49 |
Schedule of Employee Stock Options Outstanding | The following table summarizes information about employee stock options outstanding at June 30, 2023: Outstanding Options Vested Options Range of Exercise Price Number Outstanding at June 30, 2023 (000's) Weighted Average Remaining Life Weighted Average Exercise Price Number Exercisable at June 30, 2023 (000's) Weighted Average Exercise Price Weighted Average Remaining Life $0.34 - $1.05 30 0.94 $ 0.58 30 $ 0.58 0.94 $1.97 - $2.96 5 2.52 1.97 5 1.97 2.52 $3.23 - $4.85 1,377 4.01 3.81 1,378 3.81 4.01 $5.59 - $8.39 188 4.76 5.78 189 5.78 4.76 $14.53 - $21.80 60 7.09 14.53 40 14.53 7.09 $21.80 - $32.70 14 7.17 21.80 8 21.80 7.04 $42.64 - $63.96 301 7.51 42.67 200 42.67 7.51 Outstanding options 1,975 4.68 $ 10.31 1,850 $ 8.47 4.49 |
Schedule of Restricted Stock Activity | A summary of the Company’s restricted stock award activity for the six months ended June 30, 2023 and 2022 is presented in the following table: Six Months Ended June 30, 2023 June 30, 2022 Shares Weighted Shares Weighted Unvested at beginning of period — $ — 0.2 $ 14.72 Transfers to restricted stock units — — — — Granted — — — — Vested — — — — Forfeited and cancelled — — (0.2) $ 14.72 Unvested at end of period — $ — — $ — |
Schedule of Nonvested Share Activity | The value of restricted stock units that vest over time is established by the market price on the date of its grant. A summary of the Company’s restricted stock unit activity for the six months ended June 30, 2023 and 2022 is presented in the following table: Six Months Ended June 30, 2023 June 30, 2022 Shares (000's) Weighted Shares (000's) Weighted Unvested at beginning of period 539 $ 60.73 566 $ 52.66 Transfers to restricted stock awards — — — — Granted 136 103.19 202 73.33 Vested (196) 57.30 (145) 51.08 Forfeited and cancelled (42) 67.72 (42) 61.17 Unvested at end of period 437 $ 74.79 581 $ 59.62 |
Schedule of Stock-based Awards Issued to Non-employee Consultants | A summary of the Company’s PSU activity for the six months ended June 30, 2023 and 2022 is presented in the following table: Six Months Ended June 30, 2023 June 30, 2022 Shares (000's) Weighted Shares (000's) Weighted Unvested at beginning of period 76 $ 91.48 15 $ 64.65 Granted — — — — Vested — — — — Forfeited and cancelled — — — — Unvested at end of period 76 $ 91.48 15 $ 64.65 |
ORGANIZATION AND DESCRIPTION _2
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) - Transition Agreement - Convertible Preferred Stock shares in Millions, $ in Millions | Aug. 01, 2022 USD ($) shares |
Business Acquisition [Line Items] | |
Stock issued during period (in shares) | shares | 1.5 |
Proceeds from issuance of convertible preferred stock | $ | $ 550 |
BASIS OF PRESENTATION AND SUM_4
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentrations of Risk (Details) - Customer Concentration Risk | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue | ||||
Product Information [Line Items] | ||||
Total | 100% | 100% | 100% | 100% |
Revenue | Pepsi | ||||
Product Information [Line Items] | ||||
Total | 56.70% | 0% | 58.30% | 0% |
Revenue | Costco | ||||
Product Information [Line Items] | ||||
Total | 13% | 15.90% | 12.90% | 16.60% |
Revenue | All others | ||||
Product Information [Line Items] | ||||
Total | 30.30% | 84.10% | 28.80% | 83.40% |
Accounts Receivable | ||||
Product Information [Line Items] | ||||
Total | 100% | 100% | ||
Accounts Receivable | Pepsi | ||||
Product Information [Line Items] | ||||
Total | 68.40% | 47.60% | ||
Accounts Receivable | Amazon | ||||
Product Information [Line Items] | ||||
Total | 10.70% | 11.80% | ||
Accounts Receivable | All others | ||||
Product Information [Line Items] | ||||
Total | 20.90% | 40.60% |
BASIS OF PRESENTATION AND SUM_5
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Expected Credit Losses (Details) $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | |
Balance as of December 31, 2022 | $ 2,147 |
Current period change for expected credit losses | (118) |
Balance as of June 30, 2023 | $ 2,029 |
BASIS OF PRESENTATION AND SUM_6
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Long Lived Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Total long-lived assets-net | $ 28,574 | $ 23,173 |
Long-lived assets related to foreign operations | 13,532 | 13,423 |
United States | ||
Total long-lived assets-net | 15,042 | 9,750 |
Finland | ||
Long-lived assets related to foreign operations | 12,165 | 12,171 |
Sweden | ||
Long-lived assets related to foreign operations | 1,338 | 1,251 |
Other | ||
Long-lived assets related to foreign operations | $ 29 | $ 1 |
BASIS OF PRESENTATION AND SUM_7
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Thousands, shares in Millions | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2023 USD ($) shares | Jun. 30, 2022 USD ($) | Jun. 30, 2023 USD ($) shares | Jun. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) | |
Product Information [Line Items] | |||||
Amount excess of FDIC limit | $ 680,600 | $ 680,600 | $ 652,400 | ||
Restricted cash | 0 | 0 | 38,768 | ||
Inventory valuation reserves | 4,500 | 4,500 | 8,400 | ||
Contract liability | 181,200 | 181,200 | |||
Deferred revenue, non-current | 171,700 | 171,700 | |||
Deferred revenue-current | 9,500 | $ 9,500 | |||
Deferred revenue, term | 20 years | ||||
Marketing and advertising expense | 36,500 | $ 14,800 | $ 67,500 | $ 29,300 | |
Research and development expense | 200 | 100 | 500 | 200 | |
Exchange losses | (900) | (500) | (1,000) | (700) | |
Foreign currency transaction gain | 100 | ||||
Foreign currency transaction loss | $ (600) | (2,300) | (2,800) | ||
Income tax benefit | 0.50 | ||||
Freight expense | $ 14,900 | 8,500 | 29,100 | 11,400 | |
Due to Pepsi(1) | |||||
Product Information [Line Items] | |||||
Restricted cash | $ 38,800 | ||||
Contract liability | $ 181,200 | $ 189,500 | $ 181,200 | $ 189,500 | |
Maximum | |||||
Product Information [Line Items] | |||||
Estimated Useful Life in Years | 7 years | 7 years | |||
Minimum | |||||
Product Information [Line Items] | |||||
Estimated Useful Life in Years | 3 years | 3 years | |||
Stock Incentive Plan 2015 and 2016 | |||||
Product Information [Line Items] | |||||
Percentage of provision for annual increase in shares | 15% | ||||
Stock Incentive Plan 2015 and 2016 | Maximum | |||||
Product Information [Line Items] | |||||
Share-based awards (in shares) | shares | 5 | 5 |
EARNINGS PER SHARE - Schedule o
EARNINGS PER SHARE - Schedule of EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Numerator: | ||||
Net income | $ 51,509 | $ 9,158 | $ 92,736 | $ 15,838 |
Preferred Stock Dividends, Income Statement Impact | (6,856) | 0 | (13,637) | 0 |
Undistributed income | 44,653 | 9,158 | 79,099 | 15,838 |
Income allocated to participating preferred shares | (3,796) | 0 | (6,727) | 0 |
Net income attributable to common stockholders | $ 40,857 | $ 9,158 | $ 72,372 | $ 15,838 |
Denominator: | ||||
Weighted average basic common shares outstanding (in shares) | 76,845 | 75,451 | 76,759 | 75,472 |
Dilutive effect of common shares (in shares) | 2,099 | 2,921 | 2,100 | 2,925 |
Weighted average diluted shares outstanding (in shares) | 78,944 | 78,372 | 78,859 | 78,397 |
Earnings per share: | ||||
Basic (in USD per share) | $ 0.53 | $ 0.12 | $ 0.94 | $ 0.21 |
Dilutive (in USD per share) | $ 0.52 | $ 0.12 | $ 0.92 | $ 0.20 |
EARNINGS PER SHARE - Narrative
EARNINGS PER SHARE - Narrative (Details) - shares shares in Millions | 3 Months Ended | 6 Months Ended |
Jun. 30, 2023 | Jun. 30, 2023 | |
Earnings Per Share [Abstract] | ||
Potentially dilutive shares outstanding | 7.3 | 7.3 |
REVENUE - Narrative (Details)
REVENUE - Narrative (Details) - USD ($) $ in Thousands, shares in Millions | 3 Months Ended | 6 Months Ended | ||||
Aug. 01, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Promotional allowance included as a redution in revenue | $ 86,400 | $ 37,900 | $ 151,900 | $ 73,200 | ||
Accrued promotional allowance | 98,933 | 98,933 | $ 35,977 | |||
Revenue | $ 325,883 | 154,020 | $ 585,822 | 287,408 | ||
Deferred revenue, term | 20 years | |||||
Pepsi | ||||||
First cancellable term | 19 years | |||||
Cancellable term thereafter | 10 years | |||||
Total payment | $ 250,000 | |||||
Shares issued (in shares) | 1.5 | 1.5 | ||||
Upfront payment received | 227,800 | |||||
Implicit Payment | $ 282,500 | |||||
Excess fair value over issuance proceeds | $ 282,500 | |||||
License Agreement | ||||||
Revenue | 500 | 500 | $ 1,100 | 1,000 | ||
Term agreement | 50 years | |||||
Term of fixed fees | 5 years | |||||
Royalty fees | $ 6,900 | |||||
Sweden | ||||||
Revenue | $ 7,900 | $ 5,100 | $ 13,400 | $ 10,800 |
REVENUE - Schedule of Net Sales
REVENUE - Schedule of Net Sales by Reporting Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Net sales | $ 325,883 | $ 154,020 | $ 585,822 | $ 287,408 |
North America | ||||
Net sales | 310,815 | 145,409 | 559,367 | 268,882 |
Europe | ||||
Net sales | 11,909 | 7,280 | 20,561 | 15,775 |
Asia-Pacific | ||||
Net sales | 1,606 | 883 | 2,864 | 1,849 |
Other | ||||
Net sales | $ 1,553 | $ 448 | $ 3,030 | $ 902 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Inventory Disclosure [Abstract] | ||
Finished goods | $ 95,766 | $ 119,229 |
Raw materials | 61,322 | 62,491 |
Less: Inventory reserve | (4,543) | (8,431) |
Inventories-net | $ 152,545 | $ 173,289 |
PREPAID EXPENSES AND OTHER CU_2
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Disclosure Prepaid Expenses And Other Current Assets [Abstract] | ||
Prepaid expenses and other current assets | $ 23,398 | $ 11,341 |
NOTE RECEIVABLE - Schedule of N
NOTE RECEIVABLE - Schedule of Note Receivable (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Note receivable-current | $ (3,323) | $ (2,979) |
Note receivable-non-current | 0 | 3,574 |
Total | 3,323 | $ 6,553 |
Previously Reported | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Note receivable-current | (3,392) | |
Revision of Prior Period, Accounting Standards Update, Adjustment | Accounting Standards Update 2016-13 | ||
Financing Receivable, Allowance for Credit Loss [Line Items] | ||
Note receivable-current | $ (69) |
NOTE RECEIVABLE - Narrative (De
NOTE RECEIVABLE - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Weighted average interest rate | 3.21% | 3.21% | ||
Debt instrument, term | 5 years | |||
Interest income | $ 0 | $ 0.1 | $ 0.1 | $ 0.1 |
Instalment collateral shares | 30,000 | 30,000 | ||
Long-Term Debt, Term | 5 years | 5 years | ||
Minimum | ||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Weighted average interest rate | 5% | 5% | ||
Outstanding principal amount | $ 5 | |||
Maximum | ||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Weighted average interest rate | 2% | 2% | ||
Outstanding principal amount | $ 5 |
LEASES (Details)
LEASES (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Operating Leases | ||
2023 | $ 334 | |
2024 | 369 | |
2025 | 54 | |
2026 | 31 | |
2027 | 0 | |
Total future minimum lease payments | 788 | |
Less: Amount representing interest | (34) | |
Present value of lease liabilities | 754 | |
Less: current portion | (505) | $ (661) |
Long-term portion | 249 | 326 |
Finance Leases | ||
2023 | 52 | |
2024 | 40 | |
2025 | 68 | |
2026 | 65 | |
2027 | 0 | |
Total future minimum lease payments | 225 | |
Less: Amount representing interest | (11) | |
Present value of lease liabilities | 214 | |
Less: current portion | (67) | (70) |
Long-term portion | 147 | $ 162 |
Total | ||
2023 | 386 | |
2024 | 409 | |
2025 | 122 | |
2026 | 96 | |
2026 | 0 | |
Total future minimum lease payments | 1,013 | |
Less: Amount representing interest | (60) | |
Present value of lease liabilities | 953 | |
Less: current portion | (674) | |
Long-term portion | $ 279 |
PROPERTY AND EQUIPMENT - Schedu
PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Less: accumulated depreciation | $ (2,952) | $ (2,081) |
Total | $ 15,892 | 10,185 |
Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 3 years | |
Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 7 years | |
Merchandising equipment - coolers | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment | $ 14,962 | 9,885 |
Merchandising equipment - coolers | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 3 years | |
Merchandising equipment - coolers | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 7 years | |
Office equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment | $ 1,286 | 1,124 |
Office equipment | Minimum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 3 years | |
Office equipment | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 7 years | |
Vehicles | ||
Property, Plant and Equipment [Line Items] | ||
Estimated Useful Life in Years | 5 years | |
Property and equipment | $ 2,596 | $ 1,257 |
PROPERTY AND EQUIPMENT - Narrat
PROPERTY AND EQUIPMENT - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation expense | $ 600 | $ 400 | $ 953 | $ 556 |
GOODWILL AND INTANGIBLES - Narr
GOODWILL AND INTANGIBLES - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||||
Goodwill | $ 13.9 | $ 13.9 | $ 13.7 | ||
Amortized over estimated useful life | 25 years | 25 years | |||
Amortization expense | $ 0.1 | $ 0.1 | $ 0.3 | $ 0.3 |
GOODWILL AND INTANGIBLES - Sche
GOODWILL AND INTANGIBLES - Schedule of Amortization of Intangible Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Definite-lived intangible assets | ||
Customer relationships | $ 13,670 | $ 13,418 |
Less: accumulated amortization | (1,914) | (1,610) |
Definite-lived intangible assets, net | 11,756 | 11,808 |
Indefinite-lived intangible assets | ||
Brands | 446 | 2,984 |
Less: impairment | 0 | (2,576) |
Effect of exchange rate changes | 9 | 38 |
Indefinite-lived intangible assets, net | 455 | 446 |
Intangibles-net | $ 12,211 | $ 12,254 |
GOODWILL AND INTANGIBLES - Sc_2
GOODWILL AND INTANGIBLES - Schedule of Future Estimated Amortization (Details) $ in Thousands | Jun. 30, 2023 USD ($) |
Goodwill and Intangible Assets Disclosure [Abstract] | |
2023 | $ 273 |
2024 | 547 |
2025 | 547 |
2026 | 547 |
2027 | 547 |
Thereafter | 9,295 |
Total | $ 11,756 |
ACCOUNTS PAYABLE AND ACCRUED _3
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Related Party Transaction [Line Items] | ||
Accrued freight | $ 4,472 | $ 8,532 |
Accrued expenses | 31,514 | 7,425 |
Accrued legal | 12,403 | 10,463 |
Unbilled purchases | 19,885 | 8,672 |
Total | 94,313 | 106,147 |
Accounts payable | ||
Related Party Transaction [Line Items] | ||
Accounts payable | 26,039 | 36,248 |
Due to Pepsi(1) | ||
Related Party Transaction [Line Items] | ||
Accounts payable | $ 0 | 34,807 |
Total | $ 34,800 |
OTHER CURRENT LIABILITIES (Deta
OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
Short-term | ||
VAT payable | $ 591 | $ 198 |
State Beverage Container Deposit | 6,518 | 3,388 |
Total | $ 7,109 | $ 3,586 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
May 17, 2023 USD ($) | Aug. 01, 2022 USD ($) member shares | Jun. 30, 2023 USD ($) Seat shares | Jun. 30, 2022 USD ($) | Jun. 30, 2023 USD ($) Seat shares | Jun. 30, 2022 USD ($) | Dec. 31, 2022 USD ($) shares | |
Related Party Transaction [Line Items] | |||||||
Number of board members | member | 9 | ||||||
Revenue | $ 325,883 | $ 154,020 | $ 585,822 | $ 287,408 | |||
Accrued promotional allowance | 98,933 | 98,933 | $ 35,977 | ||||
Accounts receivable-net | 197,811 | 197,811 | 63,311 | ||||
Accrued distributor termination fees | (3,986) | 0 | |||||
Contract liability | 181,200 | 181,200 | |||||
Accounts payable and accrued expenses | $ 94,313 | $ 94,313 | $ 106,147 | ||||
Series A Preferred Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Mezzanine equity, shares issued (in shares) | shares | 1,467 | 1,467 | 1,467 | ||||
Issuance of series A, fair value | $ 832,500 | ||||||
Related Party | |||||||
Related Party Transaction [Line Items] | |||||||
Mezzanine equity, shares issued (in shares) | shares | 1,500 | ||||||
Percentage owned by Pepsi | 8.50% | ||||||
Number of board members | Seat | 1 | 1 | |||||
Revenue | $ 184,900 | $ 341,400 | |||||
Accrued promotional allowance | 49,500 | 49,500 | |||||
Accounts receivable-net | 138,000 | 138,000 | $ 31,600 | ||||
Accrued distributor termination fees | 227,800 | ||||||
Contract liability | 181,200 | 189,500 | 181,200 | 189,500 | |||
Revenue recognized | (2,300) | (4,200) | (4,700) | ||||
Accounts payable and accrued expenses | $ 34,800 | ||||||
Deferred contract asset in other assets | 282,500 | 282,500 | |||||
Accumulated amortization | 3,600 | 7,100 | $ 3,600 | $ 7,100 | |||
Related Party | Contract Assets Current | |||||||
Related Party Transaction [Line Items] | |||||||
Unamortized deferred contract costs | 14,100 | 14,100 | |||||
Related Party | Contract Assets Non Current | |||||||
Related Party Transaction [Line Items] | |||||||
Unamortized deferred contract costs | 255,400 | $ 262,500 | |||||
Related Party | Series A Preferred Stock | |||||||
Related Party Transaction [Line Items] | |||||||
Issuance of series A, fair value | $ 832,500 | 832,500 | |||||
Proceeds from issuance of common stock | $ 550,000 | ||||||
Deferred contract asset in other assets, representing the excess | 550,000 | ||||||
Majority Shareholder | CD Financial, LLC | Building | |||||||
Related Party Transaction [Line Items] | |||||||
Monthly rent | $ 8 | $ 35 |
MEZZANINE EQUITY - Narrative (D
MEZZANINE EQUITY - Narrative (Details) $ / shares in Units, shares in Thousands, $ in Millions | 3 Months Ended | 6 Months Ended | ||||
Aug. 01, 2022 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) $ / shares shares | Jun. 30, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) $ / shares shares | Sep. 01, 2022 Seat | Aug. 31, 2022 Seat | |
Class of Stock [Line Items] | ||||||
Number of seats | Seat | 9 | 8 | ||||
Percentage of voting right, preferred stock | 50% | |||||
Series A Preferred Stock | ||||||
Class of Stock [Line Items] | ||||||
Temporary equity, shares authorized (in shares) | shares | 1,500 | 1,500 | 1,500 | |||
Mezzanine equity, par value (in USD per share) | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | |||
Mezzanine equity, stated value (in USD per share) | $ / shares | $ 375 | $ 375 | $ 375 | |||
Mezzanine equity, shares issued (in shares) | shares | 1,467 | 1,467 | 1,467 | |||
Issuance of series A, fair value | $ | $ 832.5 | |||||
Per share of aggregate fair value of preferred share (in USD per share) | $ / shares | $ 568 | |||||
Debt issuance costs | $ | $ 8 | |||||
Preferred stock, liquidation preference, value | $ | $ 550 | $ 550 | $ 550 | |||
Accrued dividend | 5% | |||||
Dividends | $ | $ (6.9) | $ (13.6) | ||||
Preferred stock, dividends per share (in USD per share) | $ / shares | $ (4.67) | $ (9.30) | ||||
Preferred stock, dividend rate | 5% | 5% | ||||
Debt conversion price (in USD per share) | $ / shares | $ 75 | $ 75 | ||||
Common stock issued upon conversion (in shares) | shares | 7,300 | 7,300 | ||||
Series A Preferred Stock | Minimum | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, conversion ratio | 1 | 1 | ||||
Series A Preferred Stock | Maximum | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, conversion ratio | 5 | 5 | ||||
Series A Preferred Stock | Securities Purchase Agreement | ||||||
Class of Stock [Line Items] | ||||||
Mezzanine equity, shares issued (in shares) | shares | 1,500 | |||||
Percentage of share authorized | 100% | |||||
Cash consideration to related party | $ | $ 550 | |||||
Common stock, other shares outstanding (in shares) | shares | 3,700 | 3,700 | ||||
8% | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, dividend rate | 8% | |||||
10% | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, dividend rate | 10% | |||||
12% | ||||||
Class of Stock [Line Items] | ||||||
Preferred stock, dividend rate | 12% |
STOCKHOLDERS_ EQUITY (Details)
STOCKHOLDERS’ EQUITY (Details) - USD ($) shares in Thousands, $ in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Subsidiary, Sale of Stock [Line Items] | ||
Proceeds from options exercised | $ 707 | $ 1,260 |
Number of options excercised (in shares) | 290 | |
Stock Incentive Plan 2015 and 2016 | ||
Subsidiary, Sale of Stock [Line Items] | ||
Number of option shares granted (in shares) | 500 | 700 |
Proceeds from options exercised | $ 700 | $ 1,300 |
Number of options excercised (in shares) | 200 | 400 |
FAIR VALUE MEASUREMENTS - Addit
FAIR VALUE MEASUREMENTS - Additional Information (Details) - Series A convertible preferred shares - $ / shares shares in Millions | 6 Months Ended | |
Aug. 01, 2022 | Jun. 30, 2023 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Preferred stock, shares issued (in shares) | 1.5 | |
Volatility Rate | 45% | |
Risk free interest rate | 2.69% | |
Preferred stock, dividend rate | 5% | 5% |
Closing price (in USD per share) | $ 98.87 | |
Debt discount rate | 12.50% |
FAIR VALUE MEASUREMENTS - Summa
FAIR VALUE MEASUREMENTS - Summary of Preferred Stock Shares (Details) $ in Thousands | Jun. 30, 2023 USD ($) |
Level 1 | |
Mezzanine equity: | |
Total | $ 0 |
Level 2 | |
Mezzanine equity: | |
Total | 824,488 |
Level 3 | |
Mezzanine equity: | |
Total | 0 |
Series A convertible preferred shares | Level 1 | |
Mezzanine equity: | |
Total | 0 |
Series A convertible preferred shares | Level 2 | |
Mezzanine equity: | |
Total | 824,488 |
Series A convertible preferred shares | Level 3 | |
Mezzanine equity: | |
Total | $ 0 |
INCOME TAXES (Details)
INCOME TAXES (Details) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Effective income tax rate | (25.80%) | (23.50%) | (22.20%) | (28.00%) |
Federal income tax rate | 21% |
STOCK-BASED COMPENSATION - Narr
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||
Apr. 30, 2015 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2022 | Mar. 31, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | Dec. 31, 2022 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Unrecognized compensation expense | $ 0 | $ 0 | ||||||
Shares authorized (in shares) | 5,000,000 | |||||||
Share-based compensation service or vesting period of grant | 10 years | |||||||
Options to purchase vested (in shares) | 1,900,000 | 1,900,000 | ||||||
Stock options issued in the period (in shares) | 0 | 0 | ||||||
Stock option issued during the period | 229 | $ 478 | $ 450 | $ 810 | ||||
Unrecognized pre-tax non-cash compensation expense | 1,600 | 5,500 | $ 1,600 | $ 5,500 | ||||
Period of recognition of compensation expense | 6 months | |||||||
Unrecognized compensation expense, restricted stock | $ 0 | $ 0 | ||||||
Outstanding (in shares) | 0 | 0 | ||||||
Restricted Stock | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Granted (in shares) | 0 | 0 | ||||||
Vested (in shares) | 0 | 0 | ||||||
Restricted Stock Units (RSUs) | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Period of recognition of compensation expense | 2 years | |||||||
Unrecognized compensation expense, restricted stock | $ 24,000 | 25,800 | $ 24,000 | $ 25,800 | ||||
Granted (in shares) | 136,000 | 202,000 | ||||||
Vested (in shares) | 196,000 | 145,000 | ||||||
Performance Shares | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Share-based compensation service or vesting period of grant | 5 years | |||||||
Unrecognized pre-tax non-cash compensation expense | 2,100 | 800 | $ 2,100 | $ 800 | ||||
Period of recognition of compensation expense | 1 year 1 month 6 days | |||||||
Aggregate target payout | $ 7,500 | |||||||
Immediate vesting of shares | 20% | |||||||
Granted (in shares) | 0 | 0 | ||||||
Vested (in shares) | 0 | 0 | ||||||
Vested | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Fair value of shares vested | $ 20,500 | $ 7,400 | ||||||
General and Administrative Expene | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Share-based payment arrangement expense | $ 5,700 | $ 4,200 | $ 11,200 | $ 8,500 | ||||
Minimum | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Share-based compensation service or vesting period of grant | 2 years | |||||||
Maximum | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Share-based compensation service or vesting period of grant | 3 years | |||||||
Stock Incentive Plan | ||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||
Plan expiration term | 10 years | |||||||
Percentage of provision for annual increase in shares | 1,500% | |||||||
Provisions of options permitted (in shares) | 5,900,000 |
STOCK-BASED COMPENSATION - Blac
STOCK-BASED COMPENSATION - Black Scholes Pricing Model (Details) | 6 Months Ended |
Jun. 30, 2021 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Forfeiture Rate | 0% |
Minimum | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Expected volatility | 69.18% |
Expected term | 4 years 5 months 26 days |
Risk-free interest rate | 0.32% |
Maximum | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |
Expected volatility | 81.11% |
Expected term | 5 years |
Risk-free interest rate | 1.39% |
STOCK-BASED COMPENSATION - Outs
STOCK-BASED COMPENSATION - Outstanding Stock Options (Details) $ / shares in Units, shares in Thousands, $ in Thousands | 6 Months Ended |
Jun. 30, 2023 USD ($) $ / shares shares | |
Shares | |
Options outstanding, beginning balance (in shares) | shares | 2,266 |
Exercised (in shares) | shares | (290) |
Forfeiture and cancelled (in shares) | shares | (1) |
Options outstanding, ending balance (in shares) | shares | 1,975 |
Exercisable (in shares) | shares | 1,850 |
Exercise Price | |
Exercise price, beginning balance (in USD per share) | $ 9.66 |
Exercised (in USD per share) | 5.20 |
Forfeiture and cancelled (in USD per share) | 18.17 |
Exercise price, ending balance (in USD per share) | 10.31 |
Excersiable (in USD per share) | 8.47 |
Grant Date Fair Value | |
Grant date fair value, exercised (in USD per share) | $ 102.03 |
Aggregate Intrinsic Value | |
At December 31, 2022 | $ | $ 213,914 |
Exercised | $ | 28,070 |
At June 30, 2023 | $ | 274,461 |
Exercisable at June 30, 2023 | $ | $ 260,268 |
Weighted Average Remaining Term | |
At December 31, 2022 | 5 years 5 months 4 days |
At June 30, 2023 | 4 years 8 months 4 days |
Exercisable at June 30, 2023 | 4 years 5 months 26 days |
STOCK-BASED COMPENSATION - Empl
STOCK-BASED COMPENSATION - Employee Stock Options (Details) shares in Thousands | 6 Months Ended |
Jun. 30, 2023 $ / shares shares | |
Outstanding Options | |
Number outstanding (in shares) | shares | 1,975 |
Weighted Average Remaining Life | 4 years 8 months 4 days |
Weighted average exercise price (in USD per share) | $ 10.31 |
Vested Options | |
Number excercisable (in shares) | shares | 1,850 |
Weighted average exercise price (in USD per share) | $ 8.47 |
Weighted Average Remaining Life | 4 years 5 months 26 days |
1.05 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 0.34 |
Range of exercise price, upper (in USD per share) | $ 1.05 |
Outstanding Options | |
Number outstanding (in shares) | shares | 30 |
Weighted Average Remaining Life | 11 months 8 days |
Weighted average exercise price (in USD per share) | $ 0.58 |
Vested Options | |
Number excercisable (in shares) | shares | 30 |
Weighted average exercise price (in USD per share) | $ 0.58 |
Weighted Average Remaining Life | 11 months 8 days |
2.955 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 1.97 |
Range of exercise price, upper (in USD per share) | $ 2.96 |
Outstanding Options | |
Number outstanding (in shares) | shares | 5 |
Weighted Average Remaining Life | 2 years 6 months 7 days |
Weighted average exercise price (in USD per share) | $ 1.97 |
Vested Options | |
Number excercisable (in shares) | shares | 5 |
Weighted average exercise price (in USD per share) | $ 1.97 |
Weighted Average Remaining Life | 2 years 6 months 7 days |
4.845 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 3.23 |
Range of exercise price, upper (in USD per share) | $ 4.85 |
Outstanding Options | |
Number outstanding (in shares) | shares | 1,377 |
Weighted Average Remaining Life | 4 years 3 days |
Weighted average exercise price (in USD per share) | $ 3.81 |
Vested Options | |
Number excercisable (in shares) | shares | 1,378 |
Weighted average exercise price (in USD per share) | $ 3.81 |
Weighted Average Remaining Life | 4 years 3 days |
8.385 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 5.59 |
Range of exercise price, upper (in USD per share) | $ 8.39 |
Outstanding Options | |
Number outstanding (in shares) | shares | 188 |
Weighted Average Remaining Life | 4 years 9 months 3 days |
Weighted average exercise price (in USD per share) | $ 5.78 |
Vested Options | |
Number excercisable (in shares) | shares | 189 |
Weighted average exercise price (in USD per share) | $ 5.78 |
Weighted Average Remaining Life | 4 years 9 months 3 days |
21.795 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 14.53 |
Range of exercise price, upper (in USD per share) | $ 21.80 |
Outstanding Options | |
Number outstanding (in shares) | shares | 60 |
Weighted Average Remaining Life | 7 years 1 month 2 days |
Weighted average exercise price (in USD per share) | $ 14.53 |
Vested Options | |
Number excercisable (in shares) | shares | 40 |
Weighted average exercise price (in USD per share) | $ 14.53 |
Weighted Average Remaining Life | 7 years 1 month 2 days |
32.7 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 21.80 |
Range of exercise price, upper (in USD per share) | $ 32.70 |
Outstanding Options | |
Number outstanding (in shares) | shares | 14 |
Weighted Average Remaining Life | 7 years 2 months 1 day |
Weighted average exercise price (in USD per share) | $ 21.80 |
Vested Options | |
Number excercisable (in shares) | shares | 8 |
Weighted average exercise price (in USD per share) | $ 21.80 |
Weighted Average Remaining Life | 7 years 14 days |
63.96 | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] | |
Range of exercise price, lower (in USD oer share) | $ 42.64 |
Range of exercise price, upper (in USD per share) | $ 63.96 |
Outstanding Options | |
Number outstanding (in shares) | shares | 301 |
Weighted Average Remaining Life | 7 years 6 months 3 days |
Weighted average exercise price (in USD per share) | $ 42.67 |
Vested Options | |
Number excercisable (in shares) | shares | 200 |
Weighted average exercise price (in USD per share) | $ 42.67 |
Weighted Average Remaining Life | 7 years 6 months 3 days |
STOCK-BASED COMPENSATION - Rest
STOCK-BASED COMPENSATION - Restricted Stock Activity (Details) - $ / shares | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Restricted Stock | ||
Shares | ||
Unvested at beginning of period (in shares) | 0 | 200 |
Granted (in shares) | 0 | 0 |
Vested (in shares) | 0 | 0 |
Forfeited and cancelled (in shares) | 0 | (200) |
Unvested at end of period (in shares) | 0 | 0 |
Weighted Average Grant Date Fair Value | ||
Unvested at beginning of period (in USD per share) | $ 0 | $ 14.72 |
Granted (in USD per share) | 0 | 0 |
Vested (in USD per share) | 0 | 0 |
Forfeited and cancelled (in USD per share) | 0 | 14.72 |
Unvested at end of period (in USD per share) | $ 0 | $ 0 |
Restricted Stock Units (RSUs) | ||
Shares | ||
Unvested at beginning of period (in shares) | 539,000 | 566,000 |
Granted (in shares) | 136,000 | 202,000 |
Vested (in shares) | (196,000) | (145,000) |
Forfeited and cancelled (in shares) | (42,000) | (42,000) |
Unvested at end of period (in shares) | 437,000 | 581,000 |
Weighted Average Grant Date Fair Value | ||
Unvested at beginning of period (in USD per share) | $ 60.73 | $ 52.66 |
Granted (in USD per share) | 103.19 | 73.33 |
Vested (in USD per share) | 57.30 | 51.08 |
Forfeited and cancelled (in USD per share) | 67.72 | 61.17 |
Unvested at end of period (in USD per share) | $ 74.79 | $ 59.62 |
STOCK-BASED COMPENSATION - Perf
STOCK-BASED COMPENSATION - Performance Shares Issued to Non-employees (Details) - Performance Shares - $ / shares shares in Thousands | 6 Months Ended | |
Jun. 30, 2023 | Jun. 30, 2022 | |
Shares | ||
Unvested at beginning of period (in shares) | 76 | 15 |
Unvested at end of period (in shares) | 76 | 15 |
Weighted Average Grant Date Fair Value | ||
Unvested at beginning of period (in USD per share) | $ 91.48 | $ 64.65 |
Unvested at end of period (in USD per share) | $ 91.48 | $ 64.65 |
Granted (in shares) | 0 | 0 |
Granted (in USD per share) | $ 0 | $ 0 |
Vested (in shares) | 0 | 0 |
Vested (in USD per share) | $ 0 | $ 0 |
Forfeited and cancelled (in shares) | 0 | 0 |
Forfeited and cancelled (in USD per share) | $ 0 | $ 0 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details) - USD ($) $ in Millions | Feb. 13, 2023 | Jan. 18, 2023 | May 04, 2021 | Jul. 19, 2023 | Jun. 30, 2023 | Dec. 31, 2022 |
Loss Contingencies [Line Items] | ||||||
Compensatory damages | $ 82.6 | |||||
Reducing award damages value | $ 2.1 | |||||
Post judgement interest | 5.52% | |||||
Contingent commitment to third parties | $ 75.4 | $ 30.7 | ||||
Contractual obligations | 3.9 | |||||
Subsequent Event | Class Action Lawsuit | ||||||
Loss Contingencies [Line Items] | ||||||
Accrual for contingent loss | $ 7.9 | |||||
Minimum | ||||||
Loss Contingencies [Line Items] | ||||||
Accrued liability | $ 2.1 | |||||
Maximum | ||||||
Loss Contingencies [Line Items] | ||||||
Accrued liability | $ 82.6 | |||||
DThreeM Licensing Group | F and L | ||||||
Loss Contingencies [Line Items] | ||||||
Sales revenue bench mark receive (in shares) | 750,000 |